Processing 00000000.tx.1: Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease Lisa Skipper1, Yi Li2, Carine Bonnard1, Ratnagopal Pavanni3, Yuen Yih3, Eva Chua3,4, Wing-Kin Sung2, Louis Tan5, Meng-Cheong Wong5, Eng-King Tan3,4 and Jianjun Liu1,* 1Population Genetics and 2Information and Mathematical Sciences, Genome Institute of Singapore, Singapore 138672, 3Department of Neurology and 4Division of Research, SingHealth, Singapore General Hospital, Singapore 169611 and 5National Neuroscience Institute, Singapore, 308433 * To whom correspondence should be addressed at: Population Genetics, Genome, Genome Institute of Singapore, #02-01 60 Biopolis Street, Singapore 138672, Singapore. 

Phrase: "Comprehensive evaluation of common genetic variation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0846617:genetic evaluation [Health Care Activity]
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "within LRRK2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   799   C0017337:Gene [Gene or Genome]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "evidence for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "with sporadic Parkinson's disease Lisa Skipper1,"

Phrase: "Yi Li2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450478:LI2 [Body Location or Region]
   861   C1422805:LI2 [Gene or Genome]

Phrase: "Carine Bonnard1,"

Phrase: "Ratnagopal Pavanni3,"

Phrase: "Yuen Yih3,"

Phrase: "Eva Chua3,"

Phrase: "4,"

Phrase: "Wing-Kin Sung2,"

Phrase: "Louis Tan5,"

Phrase: "Meng-Cheong Wong5,"

Phrase: "Eng-King Tan3,"

Phrase: "4"

Phrase: "and"

Phrase: "Jianjun Liu1,"

Phrase: "* 1Population Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "and"

Phrase: "2Information"

Phrase: "and"

Phrase: "Mathematical Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Sciences [Occupation or Discipline]

Phrase: "Genome Institute of Singapore,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Singapore 138672,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037173:Singapore [Geographic Area]

Phrase: "3Department of Neurology"

Phrase: "and"

Phrase: "4Division of Research,"

Phrase: "SingHealth,"

Phrase: "Singapore General Hospital,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0037173:Singapore [Geographic Area]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Singapore 169611"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037173:Singapore [Geographic Area]

Phrase: "and"

Phrase: "5National Neuroscience Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Singapore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037173:Singapore [Geographic Area]

Phrase: "308433"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Population Genetics,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0017404:Genetics, Population [Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "Genome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]

Phrase: "Genome Institute of Singapore,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "#02-01 60 Biopolis Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0442658:Street [Manufactured Object]
   804   C1301826:Street [Finding]

Phrase: "Singapore 138672,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037173:Singapore [Geographic Area]

Phrase: "Singapore."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037173:Singapore [Geographic Area]
Processing 00000000.tx.2: Tel: +65 64788088; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+65 64788088"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.3: Fax: +65 64789059; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+65 64789059"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.4: Email: liuj3{at}gis.a-star.edu.sg Received August 15, 2005; 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "liuj3{at}gis.a-star.edu.sg"

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "August 15,"

Phrase: "2005"

Phrase: ";"
Processing 00000000.tx.5: Accepted September 30, 2005 GenBank accession no. 

Phrase: "Accepted September 30,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2005 GenBank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1510755:Accession [Intellectual Product]
   827   C1706078:Accession [Activity]

Phrase: "no."
Processing 00000000.tx.6: AY792511  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Parkinson's disease (PD) is a complex neurodegenerative disorder whose aetiologies are largely unknown. 

Phrase: "AY792511  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)"

Phrase: "is"

Phrase: "a complex neurodegenerative disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   827   C0012634:Disorder [Disease or Syndrome]

Phrase: "whose aetiologies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:aetiology [Functional Concept]
   966   C1314792:Aetiology [Functional Concept]

Phrase: "are"

Phrase: "largely unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.7: To date, mutations in six genes have been found causal for some rare familial forms of the disease and common variation within at least three of these is associated with the more common sporadic forms of PD. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "mutations in six genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0596611:gene mutations [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "causal for some rare familial forms of the disease"

Phrase: "and"

Phrase: "common variation within"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205419:Variation [Qualitative Concept]

Phrase: "at least three"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205449:Three [Quantitative Concept]
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "of these"

Phrase: "is"

Phrase: "associated with the more common sporadic forms of PD."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0205214:Common [Quantitative Concept]
   742   C0205422:Sporadic [Temporal Concept]
   742   C0348078:forms [Qualitative Concept]
   742   C0376315:Forms [Manufactured Object]
   742   C1522138:Common [Functional Concept]
   742   C3245511:common [Intellectual Product]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1522492:Form [Functional Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.8: LRRK2 is the most recently identified familial PD gene, although its role in sporadic disease is unknown. 

Phrase: "LRRK2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   799   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "the most recently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "familial PD gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "although"

Phrase: "its role in sporadic disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.9: In this study, we have performed the first comprehensive evaluation of common genetic variation within LRRK2 and investigated its contribution to risk of sporadic PD. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the first comprehensive evaluation of common genetic variation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0846617:genetic evaluation [Health Care Activity]
   744   C0220825:Evaluation [Functional Concept]
   744   C1261322:Evaluation [Health Care Activity]

Phrase: "within LRRK2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   799   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "its contribution to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880177:Contribution [Activity]

Phrase: "risk of sporadic PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035647:Risk [Qualitative Concept]
   770   C0205422:Sporadic [Temporal Concept]
Processing 00000000.tx.10: We first characterized the linkage disequilibrium within LRRK2 using a panel of densely spaced SNPs across the gene. 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the linkage disequilibrium within LRRK2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0023746:Linkage Disequilibrium [Quantitative Concept]
   739   C0023745:linkage [Molecular Function]
   739   C0281825:Disequilibrium [Finding]
   739   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a panel of densely spaced SNPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441833:Panel [Idea or Concept]
   753   C1999270:Panel [Intellectual Product]
   753   C3537156:Panel [Manufactured Object]

Phrase: "across the gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.11: We then identified a subset of tagging-SNPs (tSNP) that capture the majority of common variation within LRRK2. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a subset of tagging-SNPs (tSNP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515021:Subset [Classification]

Phrase: "that"

Phrase: "capture"

Phrase: "the majority of common variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "within LRRK2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   799   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.12: Both single tSNP and tSNP haplotype analyses, using a large epidemiologically matched sporadic casecontrol series comprising 932 individuals, yielded significant evidence for disease association. 

Phrase: "Both single tSNP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C2985510:Tagging SNP [Nucleotide Sequence]
   827   C0752046:SNPs [Nucleotide Sequence]
   793 E C1527094:SNP [Conceptual Entity]

Phrase: "and"

Phrase: "tSNP haplotype analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a large epidemiologically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0549177:Large [Quantitative Concept]

Phrase: "matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:matched [Research Activity]
  1000   C1708943:Matched [Qualitative Concept]

Phrase: "sporadic casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "comprising"

Phrase: "932 individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "yielded"

Phrase: "significant evidence for disease association."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.13: We identified a haplotype that dramatically increases disease risk when present in two copies (OR=5.5, 95%CI=2.114.0, P=0.0001). 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "that dramatically"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "disease risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1281905:disease risk [Finding]
   861   C0035647:Risk [Qualitative Concept]

Phrase: "when"

Phrase: "present in two copies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "(OR=5.5,"

Phrase: "95%CI=2.114.0,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0067503:CI-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "P=0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.14: Thus, we provide the first evidence that common genetic variation within LRRK2 contributes to the risk of sporadic PD in the Chinese population.  

Phrase: "Thus,"

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the first evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that common genetic variation within LRRK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0042333:Genetic Variation [Natural Phenomenon or Process]
   738   C0205419:Variation [Qualitative Concept]

Phrase: "contributes to the risk of sporadic PD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0035647:Risk [Qualitative Concept]
   748   C0205422:Sporadic [Temporal Concept]
   748   C1880177:Contribute [Activity]

Phrase: "in the Chinese population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.15: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Parkinson's disease (PD) is a complex neurodegenerative disorder currently thought to affect almost one million in the USA and as many as 1.7 million in China (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)"

Phrase: "is"

Phrase: "a complex neurodegenerative disorder currently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   812   C0012634:Disorder [Disease or Syndrome]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "almost one million in the USA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1881839:One Million [Quantitative Concept]
           Million

Phrase: "and as many as 1.7 million"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1515981:And [Idea or Concept]
   748   C1881839:Million [Quantitative Concept]

Phrase: "in China"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008115:China [Geographic Area]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Clinically, PD is characterized by resting tremor, muscle rigidity, bradykinesia and postural instability (2). 

Phrase: "Clinically,"

Phrase: "PD"

Phrase: "is"

Phrase: "characterized by resting tremor,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0234379:Resting Tremor [Sign or Symptom]
   770   C0035253:Resting [Daily or Recreational Activity]
   770   C0040822:Tremor [Sign or Symptom]
   770   C1512899:resting [Cell]
   770   C1880022:Characterized [Activity]
   770   C1963252:Tremor [Finding]
   737 E C1622890:ResT [Molecular Function]

Phrase: "muscle rigidity,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0026837:Muscle Rigidity [Sign or Symptom]
           Rigidity, NOS
   861   C0026845:Muscle [Tissue]
   861   C0700109:rigidity [Natural Phenomenon or Process]
   789 E C0231517:Rigid [Individual Behavior]
   789 E C0442025:Muscular [Spatial Concept]
   789 E C1882952:RIGID [Phenomenon or Process]

Phrase: "bradykinesia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233565:Bradykinesia [Sign or Symptom]

Phrase: "and"

Phrase: "postural instability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1843921:Postural instability [Finding]
   861   C1444783:Instability [Finding]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: Dopaminergic neuronal death within the substantia nigra pars compacta of the midbrain and the presence of proteinaceous intracellular aggregates (Lewy bodies) in surviving cells are defining pathological features (3), although the pathogenic mechanisms are poorly understood at present. 

Phrase: "Dopaminergic neuronal death within the substantia nigra pars compacta of the midbrain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0011065:Death [Organism Function]
   736   C1306577:Death, NOS [Finding]
   717   C2754100:neuron death [Cell Function]

Phrase: "and"

Phrase: "the presence of proteinaceous intracellular aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: ")"

Phrase: "in surviving cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "defining"

Phrase: "pathological features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the pathogenic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood at present."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
   756   C0162340:Understand [Mental Process]
Processing 00000000.tx.18: The majority of cases are sporadic, although mutations in a handful of genes are responsible for a small proportion of rare familial forms of PD (4). 

Phrase: "The majority of cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "are"

Phrase: "sporadic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "although"

Phrase: "mutations in a handful of genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "responsible for a small proportion of rare familial forms of PD (4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1273518:Responsible [Finding]

Phrase: ")."
Processing 00000000.tx.19: Study of these familial PD genes has offered useful insight and is assisting efforts in understanding aetiologies in common forms of the disease. 

Phrase: "Study of these familial PD genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0199236:Familial Study [Diagnostic Procedure]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "offered useful insight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0233820:Insight [Mental Process]

Phrase: "and"

Phrase: "is"

Phrase: "assisting efforts in understanding aetiologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0015264:Effort [Organism Function]

Phrase: "in common forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "of the disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.20: The first familial PD gene identified was alpha-synuclein (SNCA). 

Phrase: "The first familial PD gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "was"

Phrase: "alpha-synuclein (SNCA)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.21: Mis-sense mutations are responsible for a small number of autosomal dominant PD cases (57). 

Phrase: "Mis-sense mutations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0026882:Mutations [Genetic Function]
   827   C0036658:sense [Organ or Tissue Function]
   827   C0687670:MIS [Amino Acid, Peptide, or Protein,Hormone]
   827   C1333208:MIS [Gene or Genome]
   827   C1412384:MIS [Gene or Genome]
   827   C3538735:MIS [Gene or Genome]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "responsible for a small number of autosomal dominant PD cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1273518:Responsible [Finding]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.22: A central role for SNCA in PD stems from the finding that fibrillar forms of the protein are a major structural component of LBs in both familial and sporadic cases (8). 

Phrase: "A central role for SNCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in PD"

Phrase: "stems from the finding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037088:Finding [Sign or Symptom]
   770   C0242767:Stem [Plant]
   770   C0243095:Finding [Finding]
   770   C1186763:Stem [Body Part, Organ, or Organ Component]
   770   C2825141:Finding [Finding]

Phrase: "that fibrillar forms of the protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "a major structural component of LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "in both familial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:familial [Family Group]
  1000   C0241888:Familial [Functional Concept]
   928 E C1704727:Family [Conceptual Entity]

Phrase: "and"

Phrase: "sporadic cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.23: Genomic multiplications leading to increased expression of SNCA found in other autosomal dominant PD families [PARK4 (MIM 605543)] (9,10) suggest that protein levels may be important in pathogenesis. 

Phrase: "Genomic multiplications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2911648:Multiplication [Quantitative Concept]

Phrase: "leading to increased expression of SNCA"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   767   C0861064:increased lead [Finding]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205217:Increased [Quantitative Concept]
   753   C0332152:Leading [Temporal Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1522538:Leading [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "found in other autosomal dominant PD families"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0443147:Autosomal dominant [Intellectual Product]
   748   C0015576:Families [Family Group]
   748   C0150312:Found [Quantitative Concept]
   748   C0596142:autosomal [Cell Component]
   748   C1527180:Dominant [Functional Concept]
   748   C1704727:Family [Conceptual Entity]
   714 E C0243095:Find [Finding]

Phrase: "[PARK4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1854182:Park4 [Disease or Syndrome]
  1000   C2983377:PARK4 [Gene or Genome]

Phrase: "(MIM 605543"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1426941:MIM [Gene or Genome]

Phrase: ")"

Phrase: "]"

Phrase: "(9,"

Phrase: "10"

Phrase: ")"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "important in pathogenesis."
Processing 00000000.tx.24: Polymorphic variability within the SNCA promoter is also associated with increased risk for sporadic PD (11). 

Phrase: "Polymorphic variability within the SNCA promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827666:Variability [Conceptual Entity]

Phrase: "is"

Phrase: "also"

Phrase: "associated with increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for sporadic PD (11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205422:Sporadic [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.25: Mutations in the parkin gene (PRKN) are responsible for about 50% of autosomal recessive (AR) PD cases [PARK2 (MIM 600166)] (12). 

Phrase: "Mutations in the parkin gene (PRKN)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "responsible for about 50% of autosomal recessive (AR) PD cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]

Phrase: "[PARK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARK2 [Gene or Genome]
  1000   C1868675:PARK2 [Disease or Syndrome]

Phrase: "(MIM 600166"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1426941:MIM [Gene or Genome]

Phrase: ")"

Phrase: "]"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.26: The genetic aberrations in this gene are numerous ranging from single base-pair substitutions and deletions to multiple exonic deletions and duplications. 

Phrase: "The genetic aberrations in this gene"

Phrase: "are"

Phrase: "numerous ranging from single base-pair substitutions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1514721:Range [Quantitative Concept]
   714   C2348147:Range [Quantitative Concept]
   714   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "deletions to multiple exonic deletions"

Phrase: "and"

Phrase: "duplications."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332597:duplications [Functional Concept]
   966 E C1705960:Duplication [Cell or Molecular Dysfunction]
Processing 00000000.tx.27: Although most parkin-linked disease is inherited in AR fashion, mutations have been described in sporadic cases and haploinsufficiency may also predispose to common PD (13). 

Phrase: "Although"

Phrase: "most parkin-linked disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "inherited in AR fashion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0441748:Autosomal recessive [Intellectual Product]
   760   C0439660:Inherited [Functional Concept]
   760   C0596142:autosomal [Cell Component]

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "described in sporadic cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205422:Sporadic [Temporal Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C1552738:described [Idea or Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "haploinsufficiency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2936267:Haploinsufficiency [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "also"

Phrase: "predispose to common PD (13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.28: A common promoter variant that decreases PRKN transcription is also associated with sporadic PD (14). 

Phrase: "A common promoter variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "that"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "PRKN transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1418270:parkin gene [Gene or Genome]
   734   C2983548:Parkin Gene [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "associated with sporadic PD (14"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205422:Sporadic [Temporal Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.29: A function of the parkin protein is to act as an E3 ubiquitin protein ligase within the ubiquitin proteasomal pathway (UPP) (15); 

Phrase: "A function of the parkin protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act as an E3 ubiquitin protein ligase"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   840   C0077678:Ubiquitin-Protein Ligase E3 [Amino Acid, Peptide, or Protein,Enzyme]
           ubiquitin-protein ligase
           E3 Ubiquitin Ligase
           E3 Ligase
   814   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1442769:ubiquitin-protein ligase [Gene or Genome]
   804   C1418270:E3 ubiquitin ligase [Gene or Genome]
   748   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C1537525:E3 [Gene or Genome]

Phrase: "within the ubiquitin proteasomal pathway (UPP)"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1519748:Ubiquitin-Proteasomal Pathway [Molecular Function]
   901   C1523807:proteasomal pathway [Molecular Function]
   865 E C1752727:Proteasome Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "(15"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.30: one of the principle mechanisms by which damaged/misfolded proteins are cleared in the cell. 

Phrase: "one of the principle mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "by which"

Phrase: "damaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0010957:Damage [Injury or Poisoning]
   966   C1883709:Damage [Functional Concept]

Phrase: "/misfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "cleared in the cell."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   802   C0229473:Clear cell [Cell]
   770   C0007634:Cell [Cell]
   770   C0521097:cleared [Functional Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.31: The protein product of another gene initially implicated in familial PD, UCH-L1 (16), also plays a role within the UPP. 

Phrase: "The protein product of another gene initially"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0751455:protein gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "implicated in familial PD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:familial [Family Group]
   770   C0241888:Familial [Functional Concept]

Phrase: "UCH-L1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1421309:Uch-L1 [Gene or Genome]
  1000   C3539585:UCH-L1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3541328:Uch-L1 [Gene or Genome]
   861   C0164005:UCH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "also"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role within the UPP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.32: Impairment of UPP function is observed in sporadic cases (17) and a common polymorphism that alters UCH-L1 enzymatic activity is inversely associated with risk of sporadic PD (18). 

Phrase: "Impairment of UPP function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "is"

Phrase: "observed in sporadic cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205422:Sporadic [Temporal Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "a common polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "that"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "UCH-L1 enzymatic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C2267219:Enzymatic Activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "inversely"

Phrase: "associated with risk of sporadic PD (18"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0035647:Risk [Qualitative Concept]
   748   C0205422:Sporadic [Temporal Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.33: The leucine-rich repeat kinase 2 gene (LRRK2) is the most recently identified causative gene for autosomal dominant PD (19). 

Phrase: "The leucine-rich repeat kinase 2 gene (LRRK2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   799   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "the most recently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "causative gene for autosomal dominant PD (19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0017342:Dominant gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.34: Although its biological function is unknown at present, peptide sequence analogy suggests the LRRK2 protein is a member of the ROCO family (20) that contains five conserved domains within the C-terminal half of the protein. 

Phrase: "Although"

Phrase: "its biological function"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0031845:Biological function, NOS [Physiologic Function]
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0031843:function [Physiologic Function]
   861   C0205460:biological [Qualitative Concept]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "unknown at present,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439673:Unknown [Qualitative Concept]

Phrase: "peptide sequence analogy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   863   C0597191:peptide analog [Amino Acid, Peptide, or Protein]
   827   C0679213:analogy [Idea or Concept]
   734   C0920679:peptide sequence [Amino Acid Sequence]
   727 E C0243071:Analog [Chemical Viewed Structurally]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the LRRK2 protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0664702:leucine-rich repeat protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C0033640:kinase protein [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2

Phrase: "is"

Phrase: "a member of the ROCO family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0086282:Family member [Family Group]
   783   C1611821:Family Member [Intellectual Product]
   753   C0680022:member [Population Group]
   753   C2698041:Member [Professional or Occupational Group]

Phrase: "(20"

Phrase: ")"

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "five conserved domains within the C-terminal half of the protein."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   754   C0162808:Protein Domains [Spatial Concept]
   737 E C1514562:Protein Domain [Amino Acid Sequence]
   704   C1880389:Domain [Functional Concept]
   704   C1883221:Domain [Conceptual Entity]
   704   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.35: Most LRRK2 mutations thus far identified are within exons encoding these putative functional domains and they account for up to 6% of autosomal dominant cases (21). 

Phrase: "Most LRRK2 mutations thus far"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   901   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   829   C3146409:RICH-2 [Gene or Genome]
   827   C1517773:Leucine-Rich Repeat [Amino Acid Sequence]
   807   C0596611:gene mutations [Genetic Function]
   791   C0017337:Gene [Gene or Genome]
   791   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   791   C0026882:Mutations [Genetic Function]
   791   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0205108:far [Spatial Concept]
   791   C0205341:Repeat [Functional Concept]
   791   C0699759:Rich [Qualitative Concept]
   791   C1547730:Repeat [Temporal Concept]
   791   C1705914:Repeat [Conceptual Entity]
   758 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "are within exons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1551058:Are [Quantitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "these putative functional domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "they"

Phrase: "account for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1551359:account [Idea or Concept]
   833   C2741673:Account # [Clinical Attribute]
   833   C2981730:Account [Classification]

Phrase: "up to 6%"

Phrase: "of autosomal dominant cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0443147:Autosomal dominant [Intellectual Product]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.36: The most common of these, G2019S, may also account up to 2% of sporadic cases (22). 

Phrase: "The most common of these,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]

Phrase: "G2019S,"

Phrase: "may"

Phrase: "also"

Phrase: "account up to 2% of sporadic cases"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0205422:Sporadic [Temporal Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   748   C1551359:account [Idea or Concept]
   748   C2741673:Account # [Clinical Attribute]
   748   C2981730:Account [Classification]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.37: As variation in genes initially implicated in familial PD is becoming increasingly relevant to PD in the wider community, we sought to investigate whether common variation within LRRK2 may also predispose risk to sporadic PD. 

Phrase: "As variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "in genes initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "implicated in familial PD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:familial [Family Group]
   770   C0241888:Familial [Functional Concept]

Phrase: "is"

Phrase: "becoming"

Phrase: "increasingly relevant to PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevant [Qualitative Concept]

Phrase: "in the wider community,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009462:Community [Geographic Area]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "common variation within LRRK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205419:Variation [Qualitative Concept]
   716   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]

Phrase: "may"

Phrase: "also"

Phrase: "predispose"

Phrase: "risk to sporadic PD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.38: Here, we report our findings in the first study to address this question, using a large (n=932) epidemiologically matched sporadic casecontrol series.  

Phrase: "Here,"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "our findings in the first"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "(n=932"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "epidemiologically"

Phrase: "matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:matched [Research Activity]
  1000   C1708943:Matched [Qualitative Concept]

Phrase: "sporadic casecontrol series."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]
Processing 00000000.tx.39: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  LRRK2 linkage disequilibrium and tagging-SNPs Linkage disequilibrium (LD) is defined as the non-random association of alleles at adjacent loci. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "LRRK2 linkage disequilibrium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0023746:Linkage Disequilibrium [Quantitative Concept]
   793   C0023745:linkage [Molecular Function]
   793   C0281825:Disequilibrium [Finding]
   793   C0394006:Disequilibrium [Disease or Syndrome]
   756   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2

Phrase: "and"

Phrase: "tagging-SNPs Linkage disequilibrium (LD)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0023746:Linkage Disequilibrium [Quantitative Concept]
   812   C0023745:linkage [Molecular Function]
   812   C0281825:Disequilibrium [Finding]
   812   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "is"

Phrase: "defined as the non-random association of alleles"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0002085:Alleles [Gene or Genome]
   744   C0004083:Association [Mental Process]
   744   C0034656:RANDOM [Research Activity]
   744   C0439605:Random [Qualitative Concept]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]
   744   C1518422:Non [Functional Concept]
   744   C1704788:Defined [Conceptual Entity]
   744   C3539106:Defined [Intellectual Product]

Phrase: "at adjacent loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.40: Loci and thus their allelic variants are expected to segregate independently in a randomly mating population. 

Phrase: "Loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "thus"

Phrase: "their allelic variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "are"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "segregate"

Phrase: "independently in a randomly"

Phrase: "mating"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1160186:mating [Cell Function]
  1000   C1260875:mating [Organism Function]
  1000   C1748461:mating [Cell Function]
   966 E C0682323:mate [Family Group]

Phrase: "population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.41: However, if a particular allele at one locus is found together on the same chromosome with a specific allele at a second locus, more often than expected by chance, then the loci are in linkage disequilibrium (23). 

Phrase: "However,"

Phrase: "if"

Phrase: "a particular allele at one locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "together on the same chromosome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0008633:Chromosome [Cell Component]
   760   C0445247:Same [Qualitative Concept]
   760   C1883357:Together [Qualitative Concept]

Phrase: "with a specific allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "at a second locus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "more often than"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205172:More [Functional Concept]
   790   C0332183:Often [Temporal Concept]

Phrase: "expected by chance,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237506:Chance [Qualitative Concept]
   790   C1517001:Expected [Idea or Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "are in linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C1551058:Are [Quantitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.42: Common measures of LD include D' and r2. 

Phrase: "Common measures of LD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0079809:Measures [Quantitative Concept]
   760   C1879489:Measures [Functional Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "D'"

Phrase: "and"

Phrase: "r2."
Processing 00000000.tx.43: D' values range from 1 to 1; 

Phrase: "D' values range from 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1547411:Value range [Idea or Concept]
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "to 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.44: 1 indicates complete LD and is indicative of minimal recombination between loci (three out of a possible four haplotypes exist) and r2 ranges from 0 to 1; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "indicates"

Phrase: "complete LD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   901   C1880153:Complete Linkage [Research Activity]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "is"

Phrase: "indicative of minimal recombination"

Phrase: "between loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "(three out of a possible four haplotypes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0018591:Haplotypes [Organism Attribute]
   748   C0205449:Three [Quantitative Concept]
   748   C0205450:Four [Quantitative Concept]
   748   C0332149:Possible [Qualitative Concept]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
   748   C1705910:Possible [Qualitative Concept]
   748   C2362652:Possible [Qualitative Concept]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "r2"

Phrase: "ranges from 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1514721:*Ranges [Quantitative Concept]
   790   C2348147:Range [Quantitative Concept]
   790   C3542016:Range [Intellectual Product]

Phrase: "to 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.45: 1 indicates perfect LD (only two of a possible four haplotypes exist). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "indicates"

Phrase: "perfect LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "(only two of a possible four haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205448:Two [Quantitative Concept]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.46: Perfect LD between two loci means that information for one of these is redundant. 

Phrase: "Perfect LD between two loci means"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0023746:Linkage Disequilibrium [Quantitative Concept]
   748   C0023745:linkage [Molecular Function]
   748   C0281825:Disequilibrium [Finding]
   748   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "that information for one of these"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1533716:Information [Idea or Concept]

Phrase: "is"

Phrase: "redundant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0425087:Redundant [Finding]
  1000   C1313915:Redundant [Functional Concept]
Processing 00000000.tx.47: Extensive regions showing strong LD interspersed with (usually smaller) regions in equilibrium are typically manifested as regions of limited haplotype diversity (haplotype block). 

Phrase: "Extensive regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "strong LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "interspersed with"

Phrase: "(usually smaller"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547044:Smaller [Qualitative Concept]
   861   C0700321:Smaller [Quantitative Concept]

Phrase: ")"

Phrase: "regions in equilibrium"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0017446:Region [Geographic Area]
   756   C0205147:Region [Spatial Concept]
   706 E C0205276:Regional [Spatial Concept]
   706 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "typically"

Phrase: "manifested as regions of limited haplotype diversity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0018591:Haplotype [Organism Attribute]
   748   C0205319:manifested [Functional Concept]
   748   C0439801:Limited [Functional Concept]
   748   C1280444:manifested [Qualitative Concept]
   748   C1880371:Diversity [Qualitative Concept]
   748   C3542948:Limited [Intellectual Product]
   714   C0017446:Region [Geographic Area]
   714   C0205147:Region [Spatial Concept]

Phrase: "(haplotype block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: ")."
Processing 00000000.tx.48: The identification of haplotype blocks has allowed the use of haplotype tagging-SNPs (tSNPs) in association studies, under the assumption that much of the variation can be identified with a smaller subset of SNPs, i.e. those that tag a haplotype (24). 

Phrase: "The identification of haplotype blocks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "has"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the use of haplotype tagging-SNPs (tSNPs)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "in association studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "under the assumption"

Phrase: "that much of the variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "identified with a smaller subset of SNPs,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205396:Identified [Qualitative Concept]
   748   C0547044:Smaller [Qualitative Concept]
   748   C0700321:Smaller [Quantitative Concept]
   748   C0752046:SNPs [Nucleotide Sequence]
   748   C1515021:Subset [Classification]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   714 E C1527094:SNP [Conceptual Entity]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "those"

Phrase: "that tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037293:Tag [Neoplastic Process]
  1000   C0181496:Tag [Manufactured Object]
  1000   C1710492:TAG [Gene or Genome]

Phrase: "a haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.49: We characterized the LD and haplotype structure of LRRK2 (including 10kb of sequence upstream from coding start, based on Genbank accession number AY792511) in 92 control individuals. 

Phrase: "We"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "haplotype structure of LRRK2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C1517495:Gene Structure [Gene or Genome]
   742   C0678594:Structure [Spatial Concept]
   726 E C0017366:Structural gene [Gene or Genome]
   716   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "10kb of sequence"

Phrase: "upstream from coding start,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439659:Start [Temporal Concept]

Phrase: "based on Genbank accession number AY792511"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C1708200:GenBank_Accession_Number [Intellectual Product]
   790   C1510755:Accession Number [Intellectual Product]
           Accession
   767   C2981742:Base Number [Conceptual Entity]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
   753   C0598211:GenBank [Intellectual Product]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C1706078:Accession [Activity]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: ")"

Phrase: "in 92 control individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]
Processing 00000000.tx.50: Twenty-five SNPs (Table1) with minor allele frequencies (MAF) ranging from 0.03 to 0.49 were genotyped, yielding an average density of 1SNP/6kb (Fig.1B). 

Phrase: "Twenty-five SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0752046:SNPs [Nucleotide Sequence]
   793 E C1527094:SNP [Conceptual Entity]

Phrase: "(Table1"

Phrase: ")"

Phrase: "with minor allele frequencies (MAF)"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   901   C0017270:Frequencies, Allele [Quantitative Concept]
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "ranging from 0.03"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 0.49"

Phrase: "were"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: ","

Phrase: "yielding"

Phrase: "an average density of 1SNP/6kb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.51: Seventy-eight unique multilocus haplotypes were constructed and used to calculate pair-wise D' and r2 values (Fig.1C and D). 

Phrase: "Seventy-eight unique multilocus haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "pair-wise"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1427738:WISE [Gene or Genome]
   861   C1709450:Pair [Qualitative Concept]
   789 E C0871611:wisdom [Idea or Concept]

Phrase: "D'"

Phrase: "and"

Phrase: "r2 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "(Fig.1C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.52: View this table: [in this window] [in a new window]  Table1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table1."
Processing 00000000.tx.53: SNP assay oligomer sequences  View larger version (27K): [in this window] [in a new window]  Figure1. 

Phrase: "SNP assay oligomer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure1."
Processing 00000000.tx.54: Genomic organisation and LD within LRRK2. 

Phrase: "Genomic organisation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "LD within LRRK2."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0023746:Linkage Disequilibrium [Quantitative Concept]
   742   C0023745:linkage [Molecular Function]
   742   C0281825:Disequilibrium [Finding]
   742   C0394006:Disequilibrium [Disease or Syndrome]
   716   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
Processing 00000000.tx.55: (A) Genomic organisation of LRRK2. 

Phrase: "(A) Genomic organisation of LRRK2."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C1517495:Gene Organization [Gene or Genome]
   739   C0029237:Organisation [Physiologic Function]
   739   C0029246:Organization [Organization]
   739   C0220885:organization [Qualitative Concept]
   739   C1300196:Organization [Functional Concept]
   739   C1522486:Organization [Professional or Occupational Group]
Processing 00000000.tx.56: Exons are shown as vertical lines. 

Phrase: "Exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "shown as vertical lines."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205128:Vertical [Spatial Concept]
   770   C0205132:lines [Spatial Concept]
   737   C1547282:Show [Intellectual Product]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.57: (B) Relative positions and frequencies of 25 SNPs used to determine tSNPs. 

Phrase: "(B) Relative positions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0733755:positions [Spatial Concept]
   743 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "frequencies of 25 SNPs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   770   C0439603:Frequencies [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "tSNPs."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C2985510:Tagging SNP [Nucleotide Sequence]
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]
Processing 00000000.tx.58: Vertical bars represent the position within LRRK2 (x-axis) and the frequency in 94 Chinese control individuals (y-axis). 

Phrase: "Vertical bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the position within LRRK2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0887940:Gene Position [Molecular Function]
   742   C0733755:Position [Spatial Concept]
   716   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]

Phrase: "(x-axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the frequency in 94 Chinese control individuals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "(y-axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.59: tSNPs are denoted with an asterisk. 

Phrase: "tSNPs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C2985510:Tagging SNP [Nucleotide Sequence]
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: "are"

Phrase: "denoted with an asterisk."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2945706:asterisk [Conceptual Entity]
Processing 00000000.tx.60: (C) Pair-wise r2 and (D) pair-wise D' values between 25 SNPs. 

Phrase: "(C) Pair-wise r2"

Phrase: "and ("

Phrase: "D)"

Phrase: "pair-wise D' values between 25 SNPs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.61: Values are shaded according to the key (E) such that lighter shading indicates low values (low LD) and darker shading indicates higher values (stronger LD).  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "shaded according to the key"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680240:according [Social Behavior]

Phrase: "(E)"

Phrase: "such"

Phrase: "that lighter shading"

Phrase: "indicates"

Phrase: "low values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "(low LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: ")"

Phrase: "and"

Phrase: "darker shading"

Phrase: "indicates"

Phrase: "higher values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "(stronger LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.62: Complete LD exists throughout much of the gene overall, suggestive of minimal recombination in this region. 

Phrase: "Complete LD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   901   C1880153:Complete Linkage [Research Activity]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "throughout much of the gene overall,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017337:Gene [Gene or Genome]
   753   C0282416:Overall [Intellectual Product]
   753   C1561607:Overall [Qualitative Concept]

Phrase: "suggestive of minimal recombination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332299:Suggestive of [Functional Concept]
           suggestive

Phrase: "in this region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.63: In addition, r2 values suggest that information for some SNPs is redundant. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "r2 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that information for some SNPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "is"

Phrase: "redundant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0425087:Redundant [Finding]
  1000   C1313915:Redundant [Functional Concept]
Processing 00000000.tx.64: We therefore, sought to identify tSNPs that would efficiently capture common variation within LRRK2. 

Phrase: "We therefore,"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "tSNPs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C2985510:Tagging SNP [Nucleotide Sequence]
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: "that"

Phrase: "would"

Phrase: "efficiently"

Phrase: "capture"

Phrase: "common variation within LRRK2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205419:Variation [Qualitative Concept]
   716   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
Processing 00000000.tx.65: As there is no unique definition of what constitutes a haplotype block and the number of tSNPs can be further reduced if inter-block disequilibrium is also considered (25), we used block-independent methods to identify six tSNPs (tSNPset) sufficient to uniquely distinguish 95% of all LRRK2 haplotypes with a frequency >0.01. 

Phrase: "As"

Phrase: "there"

Phrase: "is"

Phrase: "no unique definition of what"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1550452:definition [Idea or Concept]
   760   C1704788:Definition [Conceptual Entity]
   760   C3539107:Definition [Intellectual Product]

Phrase: "constitutes"

Phrase: "a haplotype block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: "and"

Phrase: "the number of tSNPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "if"

Phrase: "inter-block disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "is"

Phrase: "also"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "block-independent methods to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: "identify"

Phrase: "six tSNPs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C2985510:Tagging SNP [Nucleotide Sequence]
   827   C0752046:SNPs [Nucleotide Sequence]
   793 E C1527094:SNP [Conceptual Entity]

Phrase: "(tSNPset"

Phrase: ")"

Phrase: "sufficient to uniquely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205410:Sufficient [Qualitative Concept]

Phrase: "distinguish"

Phrase: "95% of all LRRK2 haplotypes"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   782   C1517773:Leucine-Rich Repeat [Amino Acid Sequence]
   757   C3146409:RICH-2 [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0018591:Haplotypes [Organism Attribute]
   739   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205341:Repeat [Functional Concept]
   739   C0699759:Rich [Qualitative Concept]
   739   C1547730:Repeat [Temporal Concept]
   739   C1705914:Repeat [Conceptual Entity]

Phrase: "with a frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: ">0.01."
Processing 00000000.tx.66: We also evaluated the performance of our tSNPset to predict observed haplotypic variation (measured by Rh2) and unobserved genotypic variation (measured by r2) within LRRK2. 

Phrase: "We also"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the performance of our tSNPset to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0597198:Performance [Individual Behavior]
   753   C1882330:Performance [Activity]

Phrase: "predict"

Phrase: "observed haplotypic variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variation [Qualitative Concept]

Phrase: "("

Phrase: "measured by Rh2"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C1419379:RH2 [Gene or Genome]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "unobserved genotypic variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variation [Qualitative Concept]

Phrase: "("

Phrase: "measured by r2"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: ")"

Phrase: "within LRRK2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   799   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.67: Rh2 values were found to be >0.8 between the tSNPset and all common (frequency >0.05) full haplotypes (comprising the 25 SNPs). 

Phrase: "Rh2 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be >"

Phrase: "0.8 between the tSNPset"

Phrase: "and"

Phrase: "all common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "(frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: ">0.05"

Phrase: ")"

Phrase: "full haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "("

Phrase: "comprising"

Phrase: "the 25 SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.68: Average r2 was 0.94 between the tSNPset and all remaining common (MAF>0.05) genotypes. 

Phrase: "Average r2"

Phrase: "was"

Phrase: "0.94 between the tSNPset"

Phrase: "and"

Phrase: "all"

Phrase: "remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1527428:Remaining [Qualitative Concept]

Phrase: "common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "(MAF"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   901   C0017270:Frequencies, Allele [Quantitative Concept]
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: ">0.05"

Phrase: ")"

Phrase: "genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.69: These performance levels exceed the criteria proposed by Ahmadi etal. 

Phrase: "These performance levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "exceed"

Phrase: "the criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "proposed by Ahmadi etal."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1441414:PROPOSED [Idea or Concept]
   770   C1553874:Proposed [Qualitative Concept]
   770   C1578820:Proposed [Idea or Concept]
   770   C1998054:Ahmadi [Population Group]
Processing 00000000.tx.70: (26) and indicate that our tSNPset affords only a modest reduction in power relative to genotyping all common SNPs within LRRK2. 

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: "indicate"

Phrase: "that"

Phrase: "our tSNPset"

Phrase: "affords"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a modest reduction in power"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "relative to genotyping"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "all common SNPs within LRRK2."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0752046:SNPs [Nucleotide Sequence]
   706 E C1527094:SNP [Conceptual Entity]
Processing 00000000.tx.71: Association analyses The tSNPset was genotyped in all cases (n=466) and remaining control individuals (n=374). 

Phrase: "Association analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "The tSNPset"

Phrase: "was"

Phrase: "genotyped in all cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737   C0017431:Genotype [Organism Attribute]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "(n=466"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "remaining control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]

Phrase: "(n=374"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.72: We initially carried out single marker tests of association for each LRRK2 tSNP, by calculating odds ratios under recessive, additive and dominant models (Table2). 

Phrase: "We initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out single marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "tests of association"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0004083:Association [Mental Process]
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:Tests [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "for each LRRK2 tSNP,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   795   C2985510:Tagging SNP [Nucleotide Sequence]
   793   C0752046:SNPs [Nucleotide Sequence]
   760 E C1527094:SNP [Conceptual Entity]
   756   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2

Phrase: "by calculating odds ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0028873:Odds Ratios [Quantitative Concept]
   827   C0456603:Ratios [Quantitative Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   793 E C1547037:Ratio [Intellectual Product]

Phrase: "under recessive, additive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442796:Additive [Qualitative Concept]
   861   C1550602:Additive [Substance]

Phrase: "and"

Phrase: "dominant models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "(Table2"

Phrase: ")."
Processing 00000000.tx.73: There was a marginally significant association between rs10506151 and disease under a dominant model (OR=1.3, 95%CI=1.01.7, P=0.03). 

Phrase: "There"

Phrase: "was"

Phrase: "a marginally significant association between rs10506151"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "disease under a dominant model"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0683033:disease model [Intellectual Product]
   797   C0684309:Disease model [Experimental Model of Disease]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(OR=1.3,"

Phrase: "95%CI=1.01.7,"

Phrase: "P=0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.74: However, carrying two copies greatly increased disease risk under both recessive (OR=3.7, 95%CI=1.87.8, P=0.0001) and additive models (OR=4.0, 95%CI=1.98.3, P=0.0001). 

Phrase: "However,"

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "copies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948062:Copies [Manufactured Object]

Phrase: "greatly increased disease risk under both recessive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]

Phrase: "(OR=3.7,"

Phrase: "95%CI=1.87.8,"

Phrase: "P=0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "additive models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "(OR=4.0,"

Phrase: "95%CI=1.98.3,"

Phrase: "P=0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.75: This association remains highly significant after a conservative Bonferroni correction for multiple testing (P=0.002). 

Phrase: "This association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "remains"

Phrase: "highly significant after a conservative Bonferroni correction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1299395:Highly significant [Qualitative Concept]
   748   C0237881:significant [Quantitative Concept]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]

Phrase: "for multiple testing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039593:Testing [Functional Concept]
   861   C0392366:testing [Intellectual Product]

Phrase: "(P=0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.76: View this table: [in this window] [in a new window]  Table2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table2."
Processing 00000000.tx.77: LRRK2 tSNP association tests  We next performed tSNP haplotype association analysis, as haplotype analysis may provide more power to detect association than single marker analyses alone (27). 

Phrase: "LRRK2 tSNP association tests"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0004083:Association [Mental Process]
   790   C0022885:Tests [Laboratory Procedure]
   790   C0392366:Tests [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756 E C0039593:Test [Functional Concept]
   717   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]

Phrase: "We next performed tSNP haplotype association analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0002778:Analysis [Laboratory Procedure]
   795   C0936012:Analysis [Research Activity]
   795   C1524024:analysis [Functional Concept]

Phrase: "as"

Phrase: "haplotype analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "power"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "association than single marker analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.78: tSNP haplotypes were constructed for all cases and controls and odds ratios for tSNP haplotypes (frequency >0.01) were calculated by comparing frequencies of each against all others present within the sample group (Table3). 

Phrase: "tSNP haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018591:Haplotypes [Organism Attribute]
   717   C2985510:Tagging SNP [Nucleotide Sequence]

Phrase: "were"

Phrase: "constructed for all cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
   737   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "odds ratios for tSNP haplotypes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratios [Quantitative Concept]
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "(frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: ">0.01"

Phrase: ")"

Phrase: "were"

Phrase: "calculated by comparing frequencies of each"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0439603:Frequencies [Temporal Concept]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]
   719   C1707455:Compare [Activity]

Phrase: "against all others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "present within the sample group"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0150312:Present [Quantitative Concept]
   760   C0370003:Sample [Substance]
   760   C0441833:Group [Idea or Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "(Table3"

Phrase: ")."
Processing 00000000.tx.79: Haplotype 2 is over-represented in the patient group (OR=1.4, 95%CI=1.11.8, P=0.005; corrected P=0.08); 

Phrase: "Haplotype 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "is"

Phrase: "over-represented in the patient group"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0030705:*^patient [Patient or Disabled Group]
   753   C0205136:Over [Spatial Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   719   C1882932:Represent [Activity]

Phrase: "(OR=1.4,"

Phrase: "95%CI=1.11.8,"

Phrase: "P=0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; corrected P=0.08"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0205202:Corrected [Qualitative Concept]
   779 E C2349182:Correct [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.80: an effect partly because of signals emanating from the minor allele of rs10506151 (A) carried on this haplotype. 

Phrase: "an effect partly because of signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "emanating from the minor allele of rs10506151"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002085:Allele [Gene or Genome]
   748   C0026193:Minor [Population Group]
   748   C0205165:Minor [Qualitative Concept]

Phrase: "(A)"

Phrase: "carried on this haplotype."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018591:Haplotype [Organism Attribute]
   770   C0206243:carried [Activity]
   770   C0699809:carried [Finding]
Processing 00000000.tx.81: Odds ratios for Haplotype 2 were calculated under recessive, additive and dominant models (Table4). 

Phrase: "Odds ratios for Haplotype 2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratios [Quantitative Concept]
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "calculated under recessive, additive"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0442796:Additive [Qualitative Concept]
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C1550602:Additive [Substance]

Phrase: "and"

Phrase: "dominant models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "(Table4"

Phrase: ")."
Processing 00000000.tx.82: We observed a striking association between carrying two copies and disease status, under both recessive (OR=5.2, 95%CI=2.013.3, P=0.0002; corrected P=0.0008) and additive (OR=5.5, 95%CI=2.114.0, P=0.0001; corrected P=0.0004) models. 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a striking association between carrying two copies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "disease status,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0012634:Disease [Disease or Syndrome]
   861   C0449438:Status [Qualitative Concept]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "under both recessive"

Phrase: "(OR=5.2,"

Phrase: "95%CI=2.013.3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0067503:CI-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "P=0.0002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; corrected P=0.0008"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0205202:Corrected [Qualitative Concept]
   779 E C2349182:Correct [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "additive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442796:Additive [Qualitative Concept]
  1000   C1550602:Additive [Substance]

Phrase: "(OR=5.5,"

Phrase: "95%CI=2.114.0,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0067503:CI-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "P=0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; corrected P=0.0004"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0205202:Corrected [Qualitative Concept]
   779 E C2349182:Correct [Qualitative Concept]

Phrase: ")"

Phrase: "models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]
Processing 00000000.tx.83: We also investigated a possible age of onset effect related to Haplotype 2 dosage, using KruskalWallis tests, although results were insignificant (data not shown). 

Phrase: "We also"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "a possible age of onset effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   753   C0001779:Age [Organism Attribute]

Phrase: "related to Haplotype 2 dosage,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0018591:Haplotype [Organism Attribute]
   760   C0178602:Dosage [Quantitative Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "KruskalWallis"

Phrase: "tests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:Tests [Intellectual Product]

Phrase: ","

Phrase: "although"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "insignificant"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.84: View this table: [in this window] [in a new window]  Table3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table3."
Processing 00000000.tx.85: LRRK2 tSNPset haplotype frequencies and ORs  View this table: [in this window] [in a new window]  Table4. 

Phrase: "LRRK2 tSNPset haplotype frequencies"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   829   C0017270:Gene Frequencies [Quantitative Concept]
   791   C0439603:Frequencies [Temporal Concept]
   758 E C0376249:frequency [Quantitative Concept]
   758 E C0871396:Frequency [Quantitative Concept]
   758 E C1561548:Frequency [Qualitative Concept]
   758 E C1705502:Frequency [Quantitative Concept]
   734   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   708 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "ORs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table4."
Processing 00000000.tx.86: Haplotype 2 frequencies and ORs  In addition to the identification of a risk haplotype, our results also raise the possibility that protective variants exist within LRRK2. 

Phrase: "Haplotype 2 frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "ORs  In addition to the identification of a risk haplotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0069590:ORS [Inorganic Chemical,Pharmacologic Substance]

Phrase: "our results also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that protective variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "exist within LRRK2."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   909   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   800   C1517773:Leucine-Rich Repeat [Amino Acid Sequence]
   767   C3146409:RICH-2 [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205341:Repeat [Functional Concept]
   744   C0699759:Rich [Qualitative Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]
   744   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.87: Haplotype 3 (OR=0.8, 95%CI=0.60.9, P=0.04) and to a greater extent Haplotype 11 (OR=0.2, 95%CI=0.10.7, P=0.01) are both under-represented in the case group (Table3). 

Phrase: "Haplotype 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "(OR=0.8,"

Phrase: "95%CI=0.60.9,"

Phrase: "P=0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and to a greater extent Haplotype 11"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   762   C1555603:Great extent [Qualitative Concept]
   748   C0018591:Haplotype [Organism Attribute]
   748   C0439792:Extent [Spatial Concept]
   748   C0443228:greater [Quantitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C1704243:Greater [Quantitative Concept]
   714 E C0549177:Great [Quantitative Concept]

Phrase: "(OR=0.2,"

Phrase: "95%CI=0.10.7,"

Phrase: "P=0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "are"

Phrase: "both"

Phrase: "under-represented in the case group"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0441833:Group [Idea or Concept]
   753   C0542339:Under [Spatial Concept]
   753   C0687744:group [Population Group]
   753   C0868928:Case [Functional Concept]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]
   719   C1882932:Represent [Activity]

Phrase: "(Table3"

Phrase: ")."
Processing 00000000.tx.88: In silico analysis of rs10506151 SNP rs10506151 is positioned within the intron following exon 16, 2203bp downstream of exon 16 and 692bp upstream of exon 17. 

Phrase: "In silico analysis of rs10506151 SNP rs10506151"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "positioned within the intron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   737   C0733755:Position [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "exon 16,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "2203bp downstream of exon 16"

Phrase: "and"

Phrase: "692bp upstream of exon 17."
Processing 00000000.tx.89: In silico analysis shows that the wild-type allele (C) is conserved in vertebrates through to the rat. 

Phrase: "In silico analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C3489666:In Silico [Machine Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the wild-type allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002085:Allele [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "conserved in vertebrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0042567:Vertebrates [Vertebrate]

Phrase: "through"

Phrase: "to the rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.90: In addition, the SNP is within a putative 6-mer hnRNP K binding site (ACCCAA; SNP position shown in bold).  

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "is within a putative 6-mer hnRNP K binding site"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   756   C0005456:Binding Site [Receptor]
   756   C0682969:Binding Site [Amino Acid Sequence]
   754   C1323388:ribonucleoprotein binding [Molecular Function]
   738   C0019409:Heterogeneous [Qualitative Concept]
   738   C0035544:Ribonucleoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0205145:Site [Spatial Concept]
   738   C0243122:binding [Functional Concept]
   738   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   738   C1145667:Binding [Activity]
   738   C1167298:ribonucleoprotein [Cell Component]
   738   C1167622:Binding [Molecular Function]
   738   C1515974:Site [Body Location or Region]
   738   C1708601:K' [Quantitative Concept]
   738   C2825164:Site [Spatial Concept]

Phrase: "(ACCCAA"

Phrase: "; SNP position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "shown in bold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  This study is the first to comprehensively evaluate common genetic variation within LRRK2 and assess its potential role in sporadic PD. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "the first to comprehensively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205435:First [Quantitative Concept]
   827   C1279901:First [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "common genetic variation within LRRK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0042333:Genetic Variation [Natural Phenomenon or Process]
   739   C0205419:Variation [Qualitative Concept]

Phrase: "and"

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "its potential role in sporadic PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.92: By using a powerful tSNP approach, we have identified a common haplotype that is highly over-represented within cases (P=0.005) and, when present in two copies, significantly increases disease risk (OR=5.5, 95%CI=2.114.0, P=0.0001). 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a powerful tSNP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C2985510:Tagging SNP [Nucleotide Sequence]
   827   C0752046:SNPs [Nucleotide Sequence]
   793 E C1527094:SNP [Conceptual Entity]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a common haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "that"

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "over-represented within cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205136:Over [Spatial Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
   737   C1882932:Represent [Activity]

Phrase: "(P=0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "when"

Phrase: "present in two copies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "significantly"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "disease risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1281905:disease risk [Finding]
   861   C0035647:Risk [Qualitative Concept]

Phrase: "(OR=5.5,"

Phrase: "95%CI=2.114.0,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0067503:CI-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "P=0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.93: Interestingly, this haplotype carries a SNP (rs10506151) that is within a putative hnRNP K binding site and whose wild-type allele is conserved in vertebrates. 

Phrase: "Interestingly,"

Phrase: "this haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "carries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:Carries [Finding]

Phrase: "a SNP (rs10506151"

Phrase: ")"

Phrase: "that"

Phrase: "is within a putative hnRNP K binding site"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0005456:Binding Site [Receptor]
   764   C0682969:Binding Site [Amino Acid Sequence]
   762   C1323388:ribonucleoprotein binding [Molecular Function]
   742   C0019409:Heterogeneous [Qualitative Concept]
   742   C0035544:Ribonucleoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205145:Site [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1145667:Binding [Activity]
   742   C1167298:ribonucleoprotein [Cell Component]
   742   C1167622:Binding [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C1708601:K' [Quantitative Concept]
   742   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "whose wild-type allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002085:Allele [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "is"

Phrase: "conserved in vertebrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0042567:Vertebrates [Vertebrate]
Processing 00000000.tx.94: hnRNP K is a component of the heterogeneous ribonucleoprotein (hnRNP) particle that is implicated in a variety of cellular processes including transcription and translation (28). 

Phrase: "hnRNP K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "is"

Phrase: "a component of the heterogeneous ribonucleoprotein (hnRNP) particle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "implicated in a variety of cellular processes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C0007613:Cellular Process [Cell Function]
   762   C1325880:cellular process [Cell Function]
   748   C0007634:Cellular [Cell]
   748   C0178539:Cellular [Functional Concept]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]
   714   C1184743:Process [Body Part, Organ, or Organ Component]
   714   C1522240:Process [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "translation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040712:Translation [Intellectual Product]
  1000   C0597295:translation [Molecular Function]
  1000   C1519614:Translation [Genetic Function]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.95: It is possible that this SNP is a functional variant that alters the processing of LRRK2 and directly increases disease risk. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "this SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "is"

Phrase: "a functional variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "that"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the processing of LRRK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1709694:Processing [Activity]
   716   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]

Phrase: "and"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "disease risk."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1281905:disease risk [Finding]
   861   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.96: However, given the level of LD, we observed within this gene, we postulate the association is indirect, emanating from a true risk allele in LD with rs10506151. 

Phrase: "However,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the level of LD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "we"

Phrase: "observed within this gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017337:Gene [Gene or Genome]
   770   C1441672:Observed [Functional Concept]

Phrase: "we"

Phrase: "postulate"

Phrase: "the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "is"

Phrase: "indirect,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439852:Indirect [Qualitative Concept]

Phrase: "emanating from a true risk allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002085:Allele [Gene or Genome]
   753   C0035647:Risk [Qualitative Concept]
   753   C0205238:True [Qualitative Concept]

Phrase: "in LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "with rs10506151."
Processing 00000000.tx.97: This yet-to-be-identified variant could lie anywhere between rs10506151 and all 21 SNPs from rs11564115 through rs3761863 as LD is complete (D'=1) between these SNPs (Fig.1D). 

Phrase: "This yet-to-"

Phrase: "be-"

Phrase: "identified variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "could"

Phrase: "lie"

Phrase: "anywhere between rs10506151"

Phrase: "and"

Phrase: "all 21 SNPs from rs11564115"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0752046:SNPs [Nucleotide Sequence]
   726 E C1527094:SNP [Conceptual Entity]

Phrase: "through rs3761863"

Phrase: "as LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "is"

Phrase: "complete"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205197:Complete [Qualitative Concept]
  1000   C0725685:COMPLEAT [Food]
   928 E C0439812:Completeness [Qualitative Concept]

Phrase: "("

Phrase: "D'="

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "between these SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0752046:SNPs [Nucleotide Sequence]
   966 E C1527094:SNP [Conceptual Entity]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.98: However, the identification of a risk haplotype has enabled us to prioritize 25 individuals (cases carrying two copies of Haplotype 2) out of 189 cases (cases carrying at least one minor allele of rs10506151), who are likely to harbour a variant responsible for our remarkable observations. 

Phrase: "However,"

Phrase: "the identification of a risk haplotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0150323:Risk identification [Health Care Activity]
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "has"

Phrase: "enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prioritize"

Phrase: "25 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "(cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "two copies of Haplotype 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1948062:Copies [Manufactured Object]

Phrase: ")"

Phrase: "out of 189 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "carrying at least one minor allele of rs10506151"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0002085:Allele [Gene or Genome]
   744   C0026193:Minor [Population Group]
   744   C0205165:Minor [Qualitative Concept]
   744   C0205447:One [Quantitative Concept]
   744   C0206243:Carrying [Activity]
   711 E C0699809:carry [Finding]

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "harbour"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "a variant responsible for our remarkable observations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]
Processing 00000000.tx.99: As none of the currently known LRRK2 mutations are present, detailed analysis of coding and regulatory sequences in these individuals is now justified. 

Phrase: "As"

Phrase: "none of the currently known LRRK2 mutations"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   770   C1517773:Leucine-Rich Repeat [Amino Acid Sequence]
   753   C0596611:gene mutations [Genetic Function]
   751   C3146409:RICH-2 [Gene or Genome]
   736   C0017337:Gene [Gene or Genome]
   736   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0026882:Mutations [Genetic Function]
   736   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0205309:Known [Qualitative Concept]
   736   C0205341:Repeat [Functional Concept]
   736   C0456148:None [Quantitative Concept]
   736   C0521116:Currently [Temporal Concept]
   736   C0549184:None [Quantitative Concept]
   736   C0699759:Rich [Qualitative Concept]
   736   C1547730:Repeat [Temporal Concept]
   736   C1705914:Repeat [Conceptual Entity]
   703 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "present, detailed analysis of coding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "regulatory sequences in these individuals"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   773   C0314642:Regulatory sequence [Nucleotide Sequence]
   760   C0162326:Sequences [Nucleotide Sequence]
   760   C0220905:regulatory [Regulation or Law]
   760   C1704735:Regulatory [Conceptual Entity]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "justified."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1552821:justify [Functional Concept]
Processing 00000000.tx.100: Our haplotype association analyses also suggest that protective variants may exist within LRRK2. 

Phrase: "Our haplotype association analyses also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that protective variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "may"

Phrase: "exist within LRRK2."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   909   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   800   C1517773:Leucine-Rich Repeat [Amino Acid Sequence]
   767   C3146409:RICH-2 [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205341:Repeat [Functional Concept]
   744   C0699759:Rich [Qualitative Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]
   744   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.101: However, these observations are based on marginal significance (for Haplotype 3) or small numbers (for Haplotype 11) and must be interpreted with caution. 

Phrase: "However,"

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "are"

Phrase: "based on marginal significance"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0205284:Marginal [Spatial Concept]
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]
   770   C1527178:Based [Functional Concept]
   770   C1550517:marginal [Idea or Concept]
   770   C1705938:Based [Idea or Concept]
   770   C1947914:Marginal [Qualitative Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "("

Phrase: "for Haplotype 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: ")"

Phrase: "or"

Phrase: "small numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "("

Phrase: "for Haplotype 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "must"

Phrase: "be"

Phrase: "interpreted with caution."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1285553:interpreted [Functional Concept]
Processing 00000000.tx.102: We acknowledge the possibility that our findings may represent spurious associationsa common pitfall of many association studies. 

Phrase: "We"

Phrase: "acknowledge"

Phrase: "the possibility"

Phrase: "that"

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "spurious associationsa common pitfall of many association studies."
Processing 00000000.tx.103: However, we have taken care to minimize potential confounders, in particular by using a large casecontrol series well matched in terms of age, gender and ethnicity. 

Phrase: "However,"

Phrase: "we"

Phrase: "have"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "potential confounders,"

Phrase: "in particular"

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a large casecontrol series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "well matched in terms of age,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0150103:matched [Research Activity]
   753   C0205170:Well [Qualitative Concept]
   753   C1708943:Matched [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "and"

Phrase: "ethnicity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015031:Ethnicity [Population Group]
  1000   C0243103:ethnicity [Qualitative Concept]
   928 E C0680174:ethnic [Finding]
Processing 00000000.tx.104: This strategy is also believed sufficient to attenuate the possible, and debatable effect of population stratification (27). 

Phrase: "This strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679199:strategy [Mental Process]

Phrase: "is"

Phrase: "also"

Phrase: "believed"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "the possible,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "and"

Phrase: "debatable effect of population stratification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.105: Paisan-Ruiz etal. 

Phrase: "Paisan-Ruiz etal."
Processing 00000000.tx.106: (29) recently reported negative association of four LRRK2 SNPs (two coding non-synonymous and two coding synonymous) in a smaller and unmatched Caucasian casecontrol series. 

Phrase: "(29"

Phrase: ")"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "negative association of four LRRK2 SNPs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   738   C0004083:Association [Mental Process]
   738   C0205160:Negative [Qualitative Concept]
   738   C0439849:Association [Qualitative Concept]
   738   C0596306:Association [Phenomenon or Process]
   738   C0699792:association [Social Behavior]
   738   C1513916:Negative [Finding]
   738   C2825415:Negative [Conceptual Entity]
   738   C2825491:Negative [Qualitative Concept]

Phrase: "(two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "coding"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009219:Coding [Occupational Activity]
   966 E C0805701:Code [Intellectual Product]

Phrase: "non-synonymous"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1518422:Non [Functional Concept]
   789   C0871468:Synonym [Conceptual Entity]
   789   C3541381:Synonym [Intellectual Product]

Phrase: "and"

Phrase: "two coding synonymous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   755   C0871468:Synonym [Conceptual Entity]
   755   C3541381:Synonym [Intellectual Product]

Phrase: ")"

Phrase: "in a smaller"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0547044:Smaller [Qualitative Concept]
  1000   C0700321:Smaller [Quantitative Concept]

Phrase: "and"

Phrase: "unmatched Caucasian casecontrol series."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205549:Series [Quantitative Concept]
   812   C2348044:Series [Intellectual Product]
Processing 00000000.tx.107: However, patients in this study were selected on the basis of early onset and/or family history of PD and the level of LRRK2 variation assessed was extremely limited. 

Phrase: "However,"

Phrase: "patients in this study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "selected on the basis of early onset"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1833334:Early-onset [Finding]
   748   C0332162:Onset [Qualitative Concept]
   748   C1279919:Early [Temporal Concept]
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]
   714   C1707391:Select [Activity]

Phrase: "and/or"

Phrase: "family history of PD"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0241889:Family history [Finding]
   833   C1705495:Family History [Idea or Concept]
   770   C0015576:Family [Family Group]
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0262512:History, NOS [Organism Attribute]
   770   C0262926:History [Finding]
   770   C1704727:Family [Conceptual Entity]
   770   C1705255:History [Conceptual Entity]
   770   C2004062:History [Finding]

Phrase: "and"

Phrase: "the level of LRRK2 variation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0428209:Leucine level [Laboratory Procedure]
   757   C0456948:Level 2 [Intellectual Product]
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C1547707:Level [Geographic Area]
   739   C2946261:Level [Pharmacologic Substance]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "was"

Phrase: "extremely"

Phrase: "limited."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.108: It is also possible that sporadic disease risk associated with common variation in LRRK2 is influenced by other genetic and non-genetic factors, some of which may be population specific. 

Phrase: "It"

Phrase: "is"

Phrase: "also possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that sporadic disease risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1281905:disease risk [Finding]
   827   C0035647:Risk [Qualitative Concept]

Phrase: "associated with common variation"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205214:Common [Quantitative Concept]
   770   C0205419:Variation [Qualitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in LRRK2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   799   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "influenced by other genetic"
Meta Candidates (Total=9; Excluded=7; Pruned=0; Remaining=2)
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "and"

Phrase: "non-genetic factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "some of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]
Processing 00000000.tx.109: It will therefore now be of value to investigate our findings in other populations. 

Phrase: "It"

Phrase: "will"

Phrase: "therefore now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948052:Now [Temporal Concept]

Phrase: "be of value to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1522609:Value [Quantitative Concept]
   770   C2987476:Be [Conceptual Entity]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "our findings in other populations."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]
Processing 00000000.tx.110: In conclusion, our results strongly suggest that, in addition to the established role in familial disease, LRRK2 genetic variation may indeed make a significant contribution to common forms of PD in the general community. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our results strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "in addition to the established role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "in familial disease,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0277558:Familial disease [Disease or Syndrome]
   964 E C0344339:family disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "LRRK2 genetic variation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0042333:Genetic Variation [Natural Phenomenon or Process]
   793   C0205419:Variation [Qualitative Concept]
   756   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2

Phrase: "may"

Phrase: "indeed"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "a significant contribution to common forms of PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contribution [Activity]

Phrase: "in the general community."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009462:Community [Geographic Area]
Processing 00000000.tx.111: Isolation of the responsible factors will provide further clues to understanding the pathogenesis of this complex disorder and further study is warranted.  

Phrase: "Isolation of the responsible factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0204727:Isolation [Therapeutic or Preventive Procedure]
   760   C0205409:Isolation [Functional Concept]
   760   C0220862:isolation [Laboratory Procedure]

Phrase: "will"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "further clues to understanding"

Phrase: "the pathogenesis of this complex disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]

Phrase: "and"

Phrase: "further study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "warranted."
Processing 00000000.tx.112: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Samples From the movement disorder clinics of two major tertiary institutions in Singapore (Singapore General Hospital and National Neuroscience Institute) 466 PD patients were included in this study. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Samples From the movement disorder clinics of two major tertiary institutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C0370003:Sample [Substance]
   704   C2347026:Sample [Conceptual Entity]

Phrase: "in Singapore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037173:Singapore [Geographic Area]

Phrase: "(Singapore General Hospital"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0037173:Singapore [Geographic Area]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "and"

Phrase: "National Neuroscience Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "466 PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "included in this study."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332257:included [Functional Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.113: PD diagnosis was made in accordance with the UK PD Society Brain Bank Clinical Diagnostic Criteria of PD, by two movement disorders specialists (EK Tan and L Tan). 

Phrase: "PD diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011900:Diagnosis [Finding]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "made in accordance with the UK PD Society Brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0037455:society [Organization]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   708   C1881534:Make [Functional Concept]

Phrase: "Bank"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442598:Bank [Manufactured Object]
  1000   C0872261:Bank [Manufactured Object]

Phrase: "Clinical Diagnostic Criteria of PD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0679228:diagnostic criteria [Intellectual Product]
   760   C0243161:criteria [Intellectual Product]

Phrase: "by two movement disorders specialists"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0087009:Specialists [Professional or Occupational Group]
   779 E C1611835:Specialist [Intellectual Product]
   779 E C2348234:Specialist [Professional or Occupational Group]
   706 E C2713500:Specialism [Idea or Concept]

Phrase: "(EK Tan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302595:tan [Individual Behavior]
   861   C1537110:Tan [Clinical Attribute]
   861   C3275241:Tan [Qualitative Concept]

Phrase: "and"

Phrase: "L Tan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302595:tan [Individual Behavior]
   861   C1537110:Tan [Clinical Attribute]
   861   C3275241:Tan [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.114: The mean age of disease onset (AOO) was 6012 years (range 2481), mean current age was 6511 years (range 3091) and 56% were male. 

Phrase: "The mean age of disease onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   753   C0001779:Age [Organism Attribute]

Phrase: "(AOO"

Phrase: ")"

Phrase: "was"

Phrase: "6012 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(range 2481"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "mean current age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2598519:Current age [Temporal Concept]
   827   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "6511 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(range 3091"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "56%"

Phrase: "were"

Phrase: "male."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0024554:Male [Finding]
  1000   C0086582:male [Population Group]
  1000   C1706180:Male [Qualitative Concept]
  1000   C1706428:Male [Qualitative Concept]
  1000   C1706429:Male [Organism Attribute]
Processing 00000000.tx.115: All patients were considered sporadic, as no family history of PD was evident. 

Phrase: "All patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "sporadic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "as"

Phrase: "no family history of PD"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   926   C0332123:No family history of [Finding]
           No family history
   844   C0332122:No history of [Qualitative Concept]
   806   C0241889:Family history [Finding]
   806   C0557086:No family [Finding]
   806   C1705495:Family History [Idea or Concept]
   760   C0015576:Family [Family Group]
   760   C0019664:History [Occupation or Discipline]
   760   C0019665:history [Intellectual Product]
   760   C0262512:History, NOS [Organism Attribute]
   760   C0262926:History [Finding]
   760   C1704727:Family [Conceptual Entity]
   760   C1705255:History [Conceptual Entity]
   760   C2004062:History [Finding]

Phrase: "was"

Phrase: "evident."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.116: All were of Chinese ethnicity. 

Phrase: "All"

Phrase: "were of Chinese ethnicity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008120:chinese [Language]
   770   C0015031:Ethnicity [Population Group]
   770   C0152035:Chinese [Population Group]
   770   C0243103:ethnicity [Qualitative Concept]
Processing 00000000.tx.117: None carry the common G2019S mutation (30) or any of the other 13 LRRK2 mutations reported to date (R793M, R1067Q, L1114L, I1122V, I1371V, R1441C, R1441G, R1441H, IVS31+3 A>G, IVS33+6 T>A, Y1699C, M1869T, I2020T); 

Phrase: "None"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "the common G2019S mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(30"

Phrase: ")"

Phrase: "or"

Phrase: "any of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552551:Any [Qualitative Concept]
   790   C3272371:ANY [Intellectual Product]

Phrase: "other 13 LRRK2 mutations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   812   C0596611:gene mutations [Genetic Function]
   793   C0017337:Gene [Gene or Genome]
   793   C0026882:Mutations [Genetic Function]
   760 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "reported to date"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   858   C1302584:Reported Date [Temporal Concept]
   790   C0011008:Date [Temporal Concept]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C2348077:Date [Food]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(R793M,"

Phrase: "R1067Q,"

Phrase: "L1114L,"

Phrase: "I1122V,"

Phrase: "I1371V,"

Phrase: "R1441C,"

Phrase: "R1441G,"

Phrase: "R1441H,"

Phrase: "IVS31+3 A>G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "IVS33+6 T>A,"

Phrase: "Y1699C,"

Phrase: "M1869T,"

Phrase: "I2020T"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.118: (EK Tan etal., manuscript in preparation). 

Phrase: "(EK Tan etal.,"

Phrase: "manuscript in preparation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: ")."
Processing 00000000.tx.119: Each patient was matched with an unrelated control individual (mean age 6011 years, range 2693), free of neurological disease (n=466). 

Phrase: "Each patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "was"

Phrase: "matched with an unrelated control individual"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0027361:Individual [Population Group]
   753   C0150103:matched [Research Activity]
   753   C0237401:Individual [Human]
   753   C0243148:control [Qualitative Concept]
   753   C0445356:Unrelated [Finding]
   753   C1550141:Control [Substance]
   753   C1704623:Unrelated [Qualitative Concept]
   753   C1708943:Matched [Qualitative Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "(mean age 6011 years,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C1510829:Age-Years [Temporal Concept]
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: "range 2693"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "free of neurological disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332296:free [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]

Phrase: "(n=466"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.120: Matching criteria included a similar age (maximum age difference was 10 years), same sex and ethnicity. 

Phrase: "Matching criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a similar age (maximum age difference"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C0699810:age difference [Age Group]
   804   C1705241:*Difference [Quantitative Concept]
   804   C1705242:Difference [Qualitative Concept]
   733 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "10 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "same sex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0009253:Sex [Organism Function]
   861   C0036864:Sex [Behavior]
   861   C0079399:sex [Organism Attribute]
   861   C0445247:Same [Qualitative Concept]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "ethnicity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015031:Ethnicity [Population Group]
  1000   C0243103:ethnicity [Qualitative Concept]
   928 E C0680174:ethnic [Finding]
Processing 00000000.tx.121: Institutional ethics committees approved this study and informed consent was obtained from all participants. 

Phrase: "Institutional ethics committees"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0086471:Institutional Ethics Committee [Professional or Occupational Group]
   901   C0085546:Ethics Committee [Professional or Occupational Group]
   827   C2699414:Committee [Group]
   734   C0015003:Ethics, Institutional [Idea or Concept]

Phrase: "approved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205540:Approved [Qualitative Concept]

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "informed consent"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0021430:Informed Consent [Regulation or Law]
   861   C1511481:Consent [Functional Concept]
   861   C1522154:Informed [Qualitative Concept]
   861   C1554192:consent [Idea or Concept]
   827 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827 E C0700287:inform [Health Care Activity]
   827 E C1552002:inform [Idea or Concept]

Phrase: "was"

Phrase: "obtained from all participants."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0679646:participants [Population Group]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
   737 E C2698741:Participant [Classification]
Processing 00000000.tx.122: SNP selection and genotyping Aiming for an average marker density of one SNP/5kb, 30 SNPs with a MAF >0.02 in the Chinese population (according to HapMap Project population data, URL http://www.hapmap. 

Phrase: "SNP selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036576:selection [Genetic Function]

Phrase: "and"

Phrase: "genotyping Aiming for an average marker density of one SNP/5kb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   704   C1947946:Aim [Idea or Concept]
   704   C2948600:Aim [Pharmacologic Substance]
   704   C3540471:AIM [Gene or Genome]
   704   C3540472:AIM [Functional Concept]

Phrase: "30 SNPs with a MAF"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0752046:SNPs [Nucleotide Sequence]
   714 E C1527094:SNP [Conceptual Entity]

Phrase: ">0.02 in the Chinese population"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0008120:chinese [Language]
   753   C0032659:Population [Quantitative Concept]
   753   C0152035:Chinese [Population Group]
   753   C1257890:Population [Population Group]

Phrase: "("

Phrase: "according to HapMap Project population data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "URL http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.hapmap."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3178913:HapMap [Organism Attribute]
Processing 00000000.tx.123: org/) were selected for genotyping in 92 control samples. 

Phrase: "org/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522486:ORG [Professional or Occupational Group]

Phrase: ")"

Phrase: "were"

Phrase: "selected for genotyping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1285573:Genotyping [Laboratory Procedure]
   756   C1707391:Select [Activity]

Phrase: "in 92 control samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.124: SNPs were genotyped using MALDI-TOF mass spectrometry using the Sequenom MassARRAYTM system (San Diego, CA, USA) as previously described (19). 

Phrase: "SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0752046:SNPs [Nucleotide Sequence]
   966 E C1527094:SNP [Conceptual Entity]

Phrase: "were"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MALDI-TOF mass spectrometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1518101:MALDI-TOF Mass Spectrometry [Research Activity]
   861   C0037813:Mass Spectrometry [Laboratory Procedure]
   812   C0436196:Spectrometry [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Sequenom MassARRAYTM system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.125: Briefly, multiplex genotyping assays were designed using the Sequenom DESIGNER software. 

Phrase: "Briefly,"

Phrase: "multiplex genotyping assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Sequenom DESIGNER software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.126: Initial PCR (5ng of genomic DNA) and primer extension reactions were carried out according to the Sequenom MassEXTEND protocol. 

Phrase: "Initial PCR (5ng of genomic DNA)"

Phrase: "and"

Phrase: "primer extension reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0443286:Reaction [Functional Concept]
   793   C1114821:Reaction [Clinical Attribute]
   734   C1514433:Primer Extension [Molecular Biology Research Technique]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out according to the Sequenom MassEXTEND protocol."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0439787:Out [Spatial Concept]
   748   C0442711:Protocol [Intellectual Product]
   748   C0680240:according [Social Behavior]
   748   C0849355:Out [Qualitative Concept]
   748   C1507394:Protocol [Intellectual Product]
   748   C1522729:Protocol [Intellectual Product]
   748   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.127: Primers and allele codes are shown in Table1. 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "allele codes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0919279:codes [Classification]
   827 E C0009219:code [Occupational Activity]
   827 E C0805701:Code [Intellectual Product]

Phrase: "are"

Phrase: "shown in Table1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.128: After purification, 15nl of primer extension product was analysed with a MassARRAY Sequenom-Bruker Spectrometer (Bruker Biosciences). 

Phrase: "After purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "15nl of primer extension product"

Phrase: "was"

Phrase: "analysed with a MassARRAY Sequenom-Bruker Spectrometer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0183395:Spectrometer [Medical Device]
   748   C1710143:Spectrometer [Manufactured Object]

Phrase: "(Bruker Biosciences"

Phrase: ")."
Processing 00000000.tx.129: SNPs with overall call rates <0.85 (percentage of samples giving a reliable genotype call) and/or those that significantly deviated from HardyWeinberg equilibrium (at =0.05) were excluded from further analyses (n=5). 

Phrase: "SNPs with overall call rates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0752046:SNPs [Nucleotide Sequence]
   726 E C1527094:SNP [Conceptual Entity]

Phrase: "<0.85"

Phrase: "(percentage of samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439165:Percentage [Quantitative Concept]
   790   C1549488:Percentage [Idea or Concept]
   790   C1561533:Percentage [Idea or Concept]

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a reliable genotype call"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0679006:Call [Mental Process]
   827   C1292769:c-ALL [Neoplastic Process]
   827   C1947967:Call [Functional Concept]

Phrase: ")"

Phrase: "and/or"

Phrase: "those"

Phrase: "that significantly"

Phrase: "deviated from HardyWeinberg equilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012727:Deviated [Spatial Concept]
   770   C0014653:Equilibrium [Organism Function]
   770   C1547026:Equilibrium [Quantitative Concept]

Phrase: "(at =0.05"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516077:At [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "excluded from further analyses"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C1517331:Further [Spatial Concept]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737   C0002778:Analysis [Laboratory Procedure]
   737 E C0205108:far [Spatial Concept]
   737 E C0332196:Exclude [Functional Concept]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.130: LD characterization, tSNP selection and performance evaluation Pair-wise D' and r2 values were calculated using multilocus haplotypes inferred from phase-unknown genotype data using PHASE version 2.1 (31). 

Phrase: "LD characterization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1880022:Characterization [Activity]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "tSNP selection"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   884   C2985510:Tagging SNP [Nucleotide Sequence]
   827   C0036576:selection [Genetic Function]
   827   C0752046:SNPs [Nucleotide Sequence]
   793   C0037293:Tag [Neoplastic Process]
   793   C0181496:Tag [Manufactured Object]
   793 E C1527094:SNP [Conceptual Entity]
   793   C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "performance evaluation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220825:Evaluation [Functional Concept]
   861   C1261322:Evaluation [Health Care Activity]

Phrase: "Pair-wise"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1427738:WISE [Gene or Genome]
   861   C1709450:Pair [Qualitative Concept]
   789 E C0871611:wisdom [Idea or Concept]

Phrase: "D'"

Phrase: "and"

Phrase: "r2 values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "multilocus haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "inferred from phase-unknown genotype data"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0017431:Genotype [Organism Attribute]
   753   C0205390:Phase [Temporal Concept]
   753   C0439673:Unknown [Qualitative Concept]
   753   C0679201:Inferred [Mental Process]
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]
   753   C3245504:inferred [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PHASE version 2.1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0439559:Phase 1 [Temporal Concept]
   875   C0439560:Phase 2 [Temporal Concept]
   812   C0205390:Phase [Temporal Concept]
   812   C0333052:Version [Functional Concept]
   812   C2607870:Version [Spatial Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.131: tSNPs were identified using the TSSA algorithm. 

Phrase: "tSNPs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C2985510:Tagging SNP [Nucleotide Sequence]
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TSSA algorithm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002045:algorithm [Intellectual Product]
   861   C1553907:algorithm [Laboratory Procedure]
Processing 00000000.tx.132: This is a block-independent approach that finds a minimum set of tSNPs which uniquely distinguish a certain percentage of all possible haplotypes (25). 

Phrase: "This"

Phrase: "is"

Phrase: "a block-independent approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "that"

Phrase: "finds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "a minimum"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1524031:Minimum [Qualitative Concept]
  1000   C1552614:minimum [Idea or Concept]
  1000   C2826545:MINIMUM [Quantitative Concept]
   928 E C0547040:Minimal [Qualitative Concept]
   928 E C2945599:Minimal [Qualitative Concept]

Phrase: "set of tSNPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   816   C2985510:Tagging SNP [Nucleotide Sequence]
   770   C0036849:Set [Mental Process]
   770   C0752046:SNPs [Nucleotide Sequence]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]
   737   C0037293:Tag [Neoplastic Process]
   737   C0181496:Tag [Manufactured Object]
   737 E C1527094:SNP [Conceptual Entity]
   737   C1710492:TAG [Gene or Genome]

Phrase: "which uniquely"

Phrase: "distinguish"

Phrase: "a certain percentage of all possible haplotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.133: was set at 0.95 in order that the tSNPset returned was able to uniquely distinguish 95% of all possible haplotypes. 

Phrase: "was"

Phrase: "set at 0.95"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "in order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "that"

Phrase: "the tSNPset"

Phrase: "returned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332156:Return [Qualitative Concept]

Phrase: "was"

Phrase: "able to uniquely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "distinguish"

Phrase: "95% of all possible haplotypes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018591:Haplotypes [Organism Attribute]
   760   C0332149:Possible [Qualitative Concept]
   760   C1705910:Possible [Qualitative Concept]
   760   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.134: Performance of the selected tSNPset to capture haplotypic variation within LRRK2 was assessed by calculating Rh2 between tSNP haplotypes and common (frequency >0.05) full haplotypes (comprising 25 SNPs) (32). 

Phrase: "Performance of the selected tSNPset to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0597198:Performance [Individual Behavior]
   753   C1882330:Performance [Activity]

Phrase: "capture"

Phrase: "haplotypic variation within LRRK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205419:Variation [Qualitative Concept]
   716   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]

Phrase: "was"

Phrase: "assessed by calculating Rh2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1419379:RH2 [Gene or Genome]
   770   C1441506:Calculating [Activity]
   770   C1516048:Assessed [Activity]

Phrase: "between tSNP haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018591:Haplotypes [Organism Attribute]
   717   C2985510:Tagging SNP [Nucleotide Sequence]

Phrase: "and"

Phrase: "common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "(frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: ">0.05"

Phrase: ")"

Phrase: "full haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "("

Phrase: "comprising"

Phrase: "25 SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: ")"

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.135: This value can range from 0 to 1, with 1 indicating that tSNP haplotypes can perfectly predict all common 25 SNP haplotypes. 

Phrase: "This value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "can"

Phrase: "range from 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1514721:Range [Quantitative Concept]
   790   C2348147:Range [Quantitative Concept]
   790   C3542016:Range [Intellectual Product]

Phrase: "to 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "with 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "indicating"

Phrase: "that tSNP haplotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018591:Haplotypes [Organism Attribute]
   717   C2985510:Tagging SNP [Nucleotide Sequence]

Phrase: "can"

Phrase: "perfectly"

Phrase: "predict"

Phrase: "all common 25 SNP haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.136: To evaluate tSNP performance in capturing unobserved genotypic variation within LRRK2 we performed the leave-one-out analysis (33). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "tSNP performance in capturing unobserved genotypic variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0597198:Performance [Individual Behavior]
   744   C1882330:Performance [Activity]

Phrase: "within LRRK2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   799   C0017337:Gene [Gene or Genome]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the leave-one-out analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.137: In brief, each of the 25 genotyped SNPs (k) was dropped in turn and tSNPs were selected from the remaining SNPs (k1). 

Phrase: "In brief,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282927:brief [Qualitative Concept]
  1000   C1879313:Brief [Temporal Concept]

Phrase: "each of the 25 genotyped SNPs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0752046:SNPs [Nucleotide Sequence]
   753   C1457900:Each [Quantitative Concept]
   719   C0017431:Genotype [Organism Attribute]
   719 E C1527094:SNP [Conceptual Entity]

Phrase: "(k)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "was"

Phrase: "dropped"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1705648:Dropped [Activity]
   966 E C1321095:Drop [Quantitative Concept]
   966 E C2347093:Drop [Quantitative Concept]
   966 E C2348338:Drop [Quantitative Concept]

Phrase: "in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "and"

Phrase: "tSNPs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C2985510:Tagging SNP [Nucleotide Sequence]
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: "were"

Phrase: "selected from the remaining SNPs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0752046:SNPs [Nucleotide Sequence]
   760   C1527428:Remaining [Qualitative Concept]
   726 E C1527094:SNP [Conceptual Entity]
   726   C1707391:Select [Activity]

Phrase: "(k1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3272787:K1 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.138: Haplotype r2 (possible value range 01) was then calculated between each tSNP set and remaining SNPs. 

Phrase: "Haplotype r2"

Phrase: "(possible value range 01"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1547411:Value range [Idea or Concept]
   812   C0332149:Possible [Qualitative Concept]
   812   C1514721:Range [Quantitative Concept]
   812   C1522609:Value [Quantitative Concept]
   812   C1705910:Possible [Qualitative Concept]
   812   C2348147:Range [Quantitative Concept]
   812   C2362652:Possible [Qualitative Concept]
   812   C3542016:Range [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "calculated between each tSNP"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C2985510:Tagging SNP [Nucleotide Sequence]
   760   C0444686:Calculated [Functional Concept]
   760   C0752046:SNPs [Nucleotide Sequence]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   726   C0037293:Tag [Neoplastic Process]
   726   C0181496:Tag [Manufactured Object]
   726 E C1527094:SNP [Conceptual Entity]
   726   C1710492:TAG [Gene or Genome]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "remaining SNPs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]
Processing 00000000.tx.139: This evaluation can provide an unbiased and accurate estimate of tSNP performance in predicting genotypes that are not directly assessed (34). 

Phrase: "This evaluation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220825:Evaluation [Functional Concept]
  1000   C1261322:Evaluation [Health Care Activity]

Phrase: "can"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an unbiased"

Phrase: "and"

Phrase: "accurate estimate of tSNP performance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750572:Estimate [Quantitative Concept]

Phrase: "in predicting genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "that"

Phrase: "are"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.140: Statistical analysis Odds ratios, 95%CIs and P-values were calculated using web-based simple interactive statistical analysis (SISA) tools (URL http://home.clara.net/sisa/index.htm). 

Phrase: "Statistical analysis Odds ratios,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0028873:Odds Ratios [Quantitative Concept]
   812   C0456603:Ratios [Quantitative Concept]
   812   C1610540:*Ratios [Quantitative Concept]
   779 E C1547037:Ratio [Intellectual Product]

Phrase: "95%CIs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1504308:Cis [Eukaryote]

Phrase: "and"

Phrase: "P-values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "web-based simple interactive statistical analysis (SISA) tools"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0336791:Tool [Manufactured Object]
   762   C2827396:Tool [Manufactured Object]

Phrase: "(URL http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//home.clara.net/sisa/index.htm"

Phrase: ")."
Processing 00000000.tx.141: KruskalWallis tests were carried out using Microsoft Excel 2002. 

Phrase: "KruskalWallis"

Phrase: "tests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:Tests [Intellectual Product]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Microsoft"

Phrase: "Excel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2740529:Excel [Pharmacologic Substance]

Phrase: "2002."
Processing 00000000.tx.142: In silico analysis Sequence conservation around rs10506151 was analysed using conservation tracks available at the University of California at Santa Cruz Human Genome Browser Gateway (May 2004 assembly) (URL: http://genome.ucsc.edu/cgi-bin/hg). 

Phrase: "In silico analysis Sequence conservation around rs10506151"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]
   748   C2347858:Conservation [Qualitative Concept]

Phrase: "was"

Phrase: "analysed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "conservation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347858:Conservation [Qualitative Concept]

Phrase: "tracks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040594:Track [Manufactured Object]

Phrase: "available at the University of California"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0470187:Available [Functional Concept]
           Availability of

Phrase: "at Santa Cruz Human Genome Browser Gateway"

Phrase: "(May 2004 assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: ")"

Phrase: "(URL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1710546:URL [Intellectual Product]
  1000   C3272380:URL [Intellectual Product]
  1000   C3541384:URL [Intellectual Product]

Phrase: ":"

Phrase: "http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//genome.ucsc.edu/cgi-bin/hg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025424:Hg [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   799   C2347108:Hg+ [Element, Ion, or Isotope]
   799   C2347109:Hg++ [Element, Ion, or Isotope]
   799   C2348272:Hg [Element, Ion, or Isotope]

Phrase: ")."
Processing 00000000.tx.143: Intronic regulatory sequence analysis was performed using the web-based Alternative Splicing Workbench (URL: http://www. ebi.ac.uk/asd-srv/wb.cgi).  

Phrase: "Intronic regulatory sequence analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the web-based Alternative Splicing Workbench"

Phrase: "(URL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1710546:URL [Intellectual Product]
  1000   C3272380:URL [Intellectual Product]
  1000   C3541384:URL [Intellectual Product]

Phrase: ":"

Phrase: "http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www. ebi.ac.uk/asd-srv/wb.cgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3639708:CGI [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.144: ACKNOWLEDGEMENTS  The authors gratefully acknowledge all participants in this study. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "The authors gratefully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0221193:Authors [Professional or Occupational Group]

Phrase: "acknowledge"

Phrase: "all participants in this study."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   781   C0681850:Study Participant [Group]
   781   C2349001:Study Participant [Human]
   760   C0679646:participants [Population Group]
   726 E C2698741:Participant [Classification]
Processing 00000000.tx.145: They also would like to thank Jason Ong and Seok Shin Ng for genotyping and Marie Wong for construction of Figure1. 

Phrase: "They also"

Phrase: "would like to"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Jason Ong"

Phrase: "and"

Phrase: "Seok Shin Ng for genotyping"

Phrase: "and"

Phrase: "Marie Wong for construction of Figure1."
Processing 00000000.tx.146: This study was supported by funding from the Agency for Science and Technology and Research of Singapore. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by funding"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243098:Funding [Quantitative Concept]
   790   C0376244:funding [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]

Phrase: "from the Agency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237463:Agency [Organization]

Phrase: "for Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: "and"

Phrase: "Research of Singapore."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035168:research [Research Activity]
   790   C0242481:Research [Research Activity]
Processing 00000000.tx.147: Conflict of Interest statement: The authors declare no conflicts of interest.  

Phrase: "Conflict of Interest statement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1710187:Statement [Idea or Concept]
   756   C0079152:Conflict of Interest [Idea or Concept]

Phrase: ":"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "declare"

Phrase: "no conflicts of interest."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0079152:Conflict of Interest [Idea or Concept]
           conflicts interest
   827   C0009671:Conflicts [Individual Behavior]
   827   C0543488:Interest [Mental Process]
   793 E C1705242:Conflict [Qualitative Concept]
Processing 00000000.tx.148: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Rocca, W.A. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Rocca,"

Phrase: "W."

Phrase: "A."
Processing 00000000.tx.149: (2005) Prevalence of Parkinson's disease in China. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Prevalence of Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "in China."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008115:China [Geographic Area]
Processing 00000000.tx.150: Lancet Neurol., 4, 328329.[CrossRef][ISI][Medline] Gelb, D.J., Oliver, E. and Gilman, S. 

Phrase: "Lancet Neurol.,"

Phrase: "4,"

Phrase: "328329."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gelb,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0165519:GELB [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:GELB [Gene or Genome]
  1000   C1708832:GELB [Gene or Genome]

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Oliver,"

Phrase: "E."

Phrase: "and"

Phrase: "Gilman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.151: (1999) Diagnostic criteria for Parkinson disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Diagnostic criteria for Parkinson disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0679228:diagnostic criteria [Intellectual Product]
   760   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.152: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.153: Neurol., 56, 3339.[Abstract/Free FullText] Forno, L.S. 

Phrase: "Neurol.,"

Phrase: "56,"

Phrase: "3339."

Phrase: "[Abstract/Free FullText"

Phrase: "] Forno,"

Phrase: "L.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.154: (1996) Neuropathology of Parkinson's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuropathology of Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1540677:neuropathology disease [Pathologic Function]
           neuropathology
   770   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   770   C1555824:Neuropathology [Intellectual Product]
Processing 00000000.tx.155: J. 

Phrase: "J."
Processing 00000000.tx.156: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.157: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.158: Neurol., 55, 259272.[ISI][Medline] Vila, M. and Przedborski, S. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "259272."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vila,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1061396:Vila [Eukaryote]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Przedborski,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.159: (2004) Genetic clues to the pathogenesis of Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Genetic clues to the pathogenesis of Parkinson's disease."
Processing 00000000.tx.160: Nat. 

Phrase: "Nat."
Processing 00000000.tx.161: Med., 10 (suppl.), S58S62.[CrossRef][Medline] Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. etal. 

Phrase: "Med.,"

Phrase: "10"

Phrase: "(suppl."

Phrase: ")"

Phrase: ","

Phrase: "S58S62."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. etal."
Processing 00000000.tx.162: (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in the alpha-synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.163: Science, 276, 20452047.[Abstract/Free FullText] Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "20452047."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J.T.,"

Phrase: "Schols,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.164: (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ala30Pro mutation in the gene encoding alpha-synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0596611:Gene Mutation [Genetic Function]
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.165: Nat. 

Phrase: "Nat."
Processing 00000000.tx.166: Genet., 18, 106108.[CrossRef][ISI][Medline] Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "106108."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zarranz,"

Phrase: "J.J.,"

Phrase: "Alegre,"

Phrase: "J.,"

Phrase: "Gomez-Esteban,"

Phrase: "J.C., Lezcano,"

Phrase: "E.,"

Phrase: "Ros,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ampuero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vidal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hoenicka,"

Phrase: "J.,"

Phrase: "Rodriguez,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Atares,"

Phrase: "B. etal."
Processing 00000000.tx.167: (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. 

Phrase: "(2004"

Phrase: ")"

Phrase: "The new mutation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2985439:new mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "E46K,"

Phrase: "of alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Parkinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "Lewy body dementia."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.168: Ann. 

Phrase: "Ann."
Processing 00000000.tx.169: Neurol., 55, 164173.[CrossRef][ISI][Medline] Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M. and Goedert, M. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "164173."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hasegawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.170: (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. 

Phrase: "(1998"

Phrase: ")"

Phrase: "alpha-Synuclein in filamentous inclusions of Lewy bodies"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439095:Alpha [Intellectual Product]
   744   C2003941:Alpha [Intellectual Product]
   744   C2350010:Alpha [Qualitative Concept]

Phrase: "from Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "dementia with lewy bodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.171: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.172: Natl. 

Phrase: "Natl."
Processing 00000000.tx.173: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.174: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.175: USA, 95, 64696473.[Abstract/Free FullText] Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. etal. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "95,"

Phrase: "64696473."

Phrase: "[Abstract/Free FullText"

Phrase: "] Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Johnson,"

Phrase: "J.,"

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Hague,"

Phrase: "S."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Peuralinna,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Nussbaum,"

Phrase: "R. etal."
Processing 00000000.tx.176: (2003) alpha-Synuclein locus triplication causes Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "alpha-Synuclein locus triplication"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.177: Science, 302, 841.[Free FullText] Chartier-Harlin, M.C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "302,"

Phrase: "841."

Phrase: "[Free FullText"

Phrase: "] Chartier-Harlin,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Roumier,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mouroux,"

Phrase: "V.,"

Phrase: "Douay,"

Phrase: "X.,"

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Levecque,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Larvor,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Andrieux,"

Phrase: "J.,"

Phrase: "Hulihan,"

Phrase: "M. etal."
Processing 00000000.tx.178: (2004) alpha-Synuclein locus duplication as a cause of familial Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "alpha-Synuclein locus duplication as a cause of familial Parkinson's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0332597:Duplication [Functional Concept]
   738   C1705960:Duplication [Cell or Molecular Dysfunction]
Processing 00000000.tx.179: Lancet, 364, 11671169.[CrossRef][ISI][Medline] Pals, P., Lincoln, S., Manning, J., Heckman, M., Skipper, L., Hulihan, M., Van Den Broeck, M., De Pooter, T., Cras, P., Crook, J. etal. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "364,"

Phrase: "11671169."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030360:PALS [Disease or Syndrome]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Manning,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0024554:MAN [Finding]
   966   C0025266:Man [Population Group]
   966   C0086418:Man [Human]

Phrase: "J.,"

Phrase: "Heckman,"

Phrase: "M."

Phrase: ","

Phrase: "Skipper,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Van Den Broeck,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "M."

Phrase: ","

Phrase: "De Pooter,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cras,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Crook,"

Phrase: "J. etal."
Processing 00000000.tx.180: (2004) alpha-Synuclein promoter confers susceptibility to Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "alpha-Synuclein promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]

Phrase: "confers"

Phrase: "susceptibility to Parkinson's disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.181: Ann. 

Phrase: "Ann."
Processing 00000000.tx.182: Neurol., 56, 591595.[CrossRef][ISI][Medline] Lucking, C.B., Durr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B.S., Meco, G., Denefle, P., Wood, N.W. etal. 

Phrase: "Neurol.,"

Phrase: "56,"

Phrase: "591595."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Vaughan,"

Phrase: "J.,"

Phrase: "De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Harhangi,"

Phrase: "B.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Meco,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Denefle,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W. etal."
Processing 00000000.tx.183: (2000) Association between early-onset Parkinson's disease and mutations in the parkin gene. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Association between early-onset Parkinson's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1511978:Disease Association [Temporal Concept]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "mutations in the parkin gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.184: French Parkinson's Disease Genetics Study Group. 

Phrase: "French Parkinson's Disease Genetics Study Group."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0441833:Group [Idea or Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
   799   C2603343:Study [Research Activity]
Processing 00000000.tx.185: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.186: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.187: J. 

Phrase: "J."
Processing 00000000.tx.188: Med., 342, 15601567.[Abstract/Free FullText] Mata, I.F., Lockhart, P.J. and Farrer, M.J. 

Phrase: "Med.,"

Phrase: "342,"

Phrase: "15601567."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mata,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "I.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lockhart,"

Phrase: "P.J."

Phrase: "and"

Phrase: "Farrer,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.189: (2004) Parkin genetics: one model for Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Parkin genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: ":"

Phrase: "one model for Parkinson's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0683033:disease model [Intellectual Product]
   797   C0684309:Disease model [Experimental Model of Disease]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.190: Hum. 

Phrase: "Hum."
Processing 00000000.tx.191: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.192: Genet., 13 (Spec no. 1), R127R133.[Abstract/Free FullText] West, A.B., Maraganore, D., Crook, J., Lesnick, T., Lockhart, P.J., Wilkes, K.M., Kapatos, G., Hardy, J.A. and Farrer, M.J. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "13"

Phrase: "(Spec"

Phrase: "no. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "R127R133."

Phrase: "[Abstract/Free FullText"

Phrase: "] West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "Maraganore,"

Phrase: "D."

Phrase: ","

Phrase: "Crook,"

Phrase: "J.,"

Phrase: "Lesnick,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lockhart,"

Phrase: "P.J.,"

Phrase: "Wilkes,"

Phrase: "K.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kapatos,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J."

Phrase: "A."

Phrase: "and"

Phrase: "Farrer,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.193: (2002) Functional association of the parkin gene promoter with idiopathic Parkinson's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Functional association of the parkin gene promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with idiopathic Parkinson's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030567:Idiopathic Parkinson Disease [Disease or Syndrome]
           Parkinson Disease
   913   C0277553:Idiopathic disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0332240:Idiopathic [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.194: Hum. 

Phrase: "Hum."
Processing 00000000.tx.195: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.196: Genet., 11, 27872792.[Abstract/Free FullText] Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "11,"

Phrase: "27872792."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "S."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Shimizu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Iwai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chiba,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanaka,"

Phrase: "K. etal."
Processing 00000000.tx.197: (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Familial Parkinson disease gene product,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a ubiquitin-protein ligase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0077678:ubiquitin-protein ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1442769:ubiquitin-protein ligase [Gene or Genome]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.198: Nat. 

Phrase: "Nat."
Processing 00000000.tx.199: Genet., 25, 302305.[CrossRef][ISI][Medline] Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M.J., Jonnalagada, S., Chernova, T. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "25,"

Phrase: "302305."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Leroy,"

Phrase: "E.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Auburger,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Leube,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ulm,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mezey,"

Phrase: "E.,"

Phrase: "Harta,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brownstein,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Jonnalagada,"

Phrase: "S."

Phrase: ","

Phrase: "Chernova,"

Phrase: "T. etal."
Processing 00000000.tx.200: (1998) The ubiquitin pathway in Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The ubiquitin pathway in Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1521736:Parkinson's Disease Pathway [Functional Concept]
   783   C1511986:Disease Pathway [Conceptual Entity]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.201: Nature, 395, 451452.[CrossRef][ISI][Medline] Mcnaught, K.S., Belizaire, R., Isacson, O., Jenner, P. and Olanow, C.W. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "395,"

Phrase: "451452."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mcnaught,"

Phrase: "K.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Belizaire,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Isacson,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Jenner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Olanow,"

Phrase: "C.W."
Processing 00000000.tx.202: (2003) Altered proteasomal function in sporadic Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "proteasomal function in sporadic Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
Processing 00000000.tx.203: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.204: Neurol., 179, 3846.[CrossRef][ISI][Medline] Liu, Y., Fallon, L., Lashuel, H.A., Liu, Z. and Lansbury, P.T., Jr. 

Phrase: "Neurol.,"

Phrase: "179,"

Phrase: "3846."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liu,"

Phrase: "Y.,"

Phrase: "Fallon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551604:Fallon [Population Group]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lashuel,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A.,"

Phrase: "Liu,"

Phrase: "Z."

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.205: (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. 

Phrase: "(2002"

Phrase: ")"

Phrase: "The UCH-L1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0017337:Gene [Gene or Genome]
   734   C1421309:Uch-L1 [Gene or Genome]
   734   C3539585:UCH-L1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C3541328:Uch-L1 [Gene or Genome]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "opposing"

Phrase: "enzymatic activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C2267219:Enzymatic Activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "alpha-synuclein degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]
   734   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]

Phrase: "and"

Phrase: "Parkinson's disease susceptibility."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   901   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   827   C0220898:Susceptibility [Organism Attribute]
   827   C1264642:Susceptibility [Functional Concept]
   827   C1547045:*Susceptibility [Quantitative Concept]
   755 E C0231204:Susceptible [Functional Concept]
   755 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]
Processing 00000000.tx.206: Cell, 111, 209218.[CrossRef][ISI][Medline] Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B. etal. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "111,"

Phrase: "209218."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zimprich,"

Phrase: "A.,"

Phrase: "Biskup,"

Phrase: "S."

Phrase: ","

Phrase: "Leitner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lichtner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Uitti,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Calne,"

Phrase: "D."

Phrase: "B. etal."
Processing 00000000.tx.207: (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Mutations in LRRK2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   743   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal-dominant parkinsonism with pleomorphic pathology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0752098:Autosomal Dominant Parkinsonism [Disease or Syndrome]
   753   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.208: Neuron, 44, 601607.[CrossRef][ISI][Medline] Bosgraaf, L. and Van Haastert, P.J. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "44,"

Phrase: "601607."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bosgraaf,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Van Haastert,"

Phrase: "P.J."
Processing 00000000.tx.209: (2003) Roc, a Ras/GTPase domain in complex proteins. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Roc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683187:ROC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527113:ROC [Quantitative Concept]

Phrase: "a Ras/GTPase domain in complex proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0162808:Protein Domain [Spatial Concept]
   757   C1514562:Protein Domain [Amino Acid Sequence]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.210: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.211: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.212: Acta, 1643, 510.[CrossRef][ISI][Medline] Pardo, L.M. and Van Duijn, C.M. 

Phrase: "Acta,"

Phrase: "1643,"

Phrase: "510."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pardo,"

Phrase: "L.M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Van Duijn,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.213: (2005) In search of genes involved in neurodegenerative disorders. 

Phrase: "(2005"

Phrase: ")"

Phrase: "In search of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in neurodegenerative disorders."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   833   C1522560:Neurodegenerative Disorders [Functional Concept]
   770   C0012634:Disorders [Disease or Syndrome]
   770   C1314939:Involved [Functional Concept]
Processing 00000000.tx.214: Mutat. 

Phrase: "Mutat."
Processing 00000000.tx.215: Res., in press. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "in press."
Processing 00000000.tx.216: Gilks, W.P., Abou-Sleiman, P.M., Gandhi, S., Jain, S., Singleton, A., Lees, A.J., Shaw, K., Bhatia, K.P., Bonifati, V., Quinn, N.P. etal. 

Phrase: "Gilks,"

Phrase: "W.P.,"

Phrase: "Abou-Sleiman,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Gandhi,"

Phrase: "S."

Phrase: ","

Phrase: "Jain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337694:Jain [Idea or Concept]
  1000   C1998092:Jain [Population Group]

Phrase: "S."

Phrase: ","

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Lees,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Shaw,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bhatia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2811903:Bhatia [Eukaryote]

Phrase: "K.P.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Quinn,"

Phrase: "N.P. etal."
Processing 00000000.tx.217: (2005) A common LRRK2 mutation in idiopathic Parkinson's disease. 

Phrase: "(2005"

Phrase: ")"

Phrase: "A common LRRK2 mutation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   812   C0596611:Gene Mutation [Genetic Function]
   793   C0017337:Gene [Gene or Genome]
   793   C0026882:Mutation [Genetic Function]
   793   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in idiopathic Parkinson's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030567:Idiopathic Parkinson Disease [Disease or Syndrome]
           Parkinson Disease
   913   C0277553:Idiopathic disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0332240:Idiopathic [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.218: Lancet, 365, 415416.[ISI][Medline] Cardon, L.R. and Abecasis, G.R. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "365,"

Phrase: "415416."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cardon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0997028:Cardoon [Plant]

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Abecasis,"

Phrase: "G.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.219: (2003) Using haplotype blocks to map human complex trait loci. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "human complex trait loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.220: Trends Genet., 19, 135140.[CrossRef][ISI][Medline] Johnson, G.C., Esposito, L., Barratt, B.J., Smith, A.N., Heward, J., Di Genova, G., Ueda, H., Cordell, H.J., Eaves, I.A., Dudbridge, F. etal. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "19,"

Phrase: "135140."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnson,"

Phrase: "G.C., Esposito,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Barratt,"

Phrase: "B.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A.N., Heward,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1272460:a n [Qualitative Concept]

Phrase: "J.,"

Phrase: "Di Genova,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ueda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cordell,"

Phrase: "H.J.,"

Phrase: "Eaves,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "A.,"

Phrase: "Dudbridge,"

Phrase: "F. etal."
Processing 00000000.tx.221: (2001) Haplotype tagging for the identification of common disease genes. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Haplotype tagging for the identification of common disease genes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C0037293:Tag [Neoplastic Process]
   708   C0181496:Tag [Manufactured Object]
   708   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.222: Nat. 

Phrase: "Nat."
Processing 00000000.tx.223: Genet., 29, 233237.[CrossRef][ISI][Medline] Liu, T., Sung, W.-K., Li, Y., Liu, J., Mittal, A. and Mao, P. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "29,"

Phrase: "233237."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0037173:SING [Geographic Area]
   966   C0234857:sing [Individual Behavior]

Phrase: "W.-K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y.,"

Phrase: "Liu,"

Phrase: "J.,"

Phrase: "Mittal,"

Phrase: "A."

Phrase: "and"

Phrase: "Mao,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.224: (2005) Effective algorithms for Tag SNP selection. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Effective algorithms for Tag SNP selection."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0002045:Algorithms [Intellectual Product]
   719 E C1553907:algorithm [Laboratory Procedure]
Processing 00000000.tx.225: J. 

Phrase: "J."
Processing 00000000.tx.226: Bioinf. 

Phrase: "Bioinf."
Processing 00000000.tx.227: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.228: Biol., in press. 

Phrase: "Biol.,"

Phrase: "in press."
Processing 00000000.tx.229: Ahmadi, K.R., Weale, M.E., Xue, Z.Y., Soranzo, N., Yarnall, D.P., Briley, J.D., Maruyama, Y., Kobayashi, M., Wood, N.W., Spurr, N.K. etal. 

Phrase: "Ahmadi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998054:Ahmadi [Population Group]

Phrase: "K.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Weale,"

Phrase: "M."

Phrase: "E.,"

Phrase: "Xue,"

Phrase: "Z.Y.,"

Phrase: "Soranzo,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Yarnall,"

Phrase: "D.P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Briley,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Maruyama,"

Phrase: "Y.,"

Phrase: "Kobayashi,"

Phrase: "M."

Phrase: ","

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W., Spurr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0285253:spurr [Organic Chemical]

Phrase: "N.K. etal."
Processing 00000000.tx.230: (2005) A single-nucleotide polymorphism tagging set for human drug metabolism and transport. 

Phrase: "(2005"

Phrase: ")"

Phrase: "A single-nucleotide polymorphism tagging"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0037293:Tag [Neoplastic Process]
   779   C0181496:Tag [Manufactured Object]
   779   C1710492:TAG [Gene or Genome]
   756   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]

Phrase: "set for human drug metabolism"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0683140:Drug Metabolism [Molecular Function]
   760   C0013227:Drug [Pharmacologic Substance]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0036849:Set [Mental Process]
   760   C0086418:Human [Human]
   760   C1254351:Drug [Pharmacologic Substance]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]
   704 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   704 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "transport."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]
Processing 00000000.tx.231: Nat. 

Phrase: "Nat."
Processing 00000000.tx.232: Genet., 37, 8489.[ISI][Medline] Newton-Cheh, C. and Hirschhorn, J.N. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "37,"

Phrase: "8489."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Newton-Cheh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2247496:ChEH [Molecular Function]

Phrase: "C."

Phrase: "and"

Phrase: "Hirschhorn,"

Phrase: "J.N."
Processing 00000000.tx.233: (2005) Genetic association studies of complex traits: design and analysis issues. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Genetic association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "studies of complex traits"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0439855:Complex [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0599883:traits [Organism Attribute]
   770   C0947630:studies [Laboratory Procedure]
   770   C1427926:TRAITS [Gene or Genome]
   770   C1704241:Complex [Chemical Viewed Structurally]
   770   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "design"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1707689:Design [Activity]
  1000   C2983265:DESIGN [Intellectual Product]

Phrase: "and"

Phrase: "analysis issues."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033213:Issue [Finding]
   827   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.234: Mutat. 

Phrase: "Mutat."
Processing 00000000.tx.235: Res., 573, 5469.[ISI][Medline] Bomsztyk, K., Denisenko, O. and Ostrowski, J. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "573,"

Phrase: "5469."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bomsztyk,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Denisenko,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Ostrowski,"

Phrase: "J."
Processing 00000000.tx.236: (2004) hnRNP K: one protein multiple processes. 

Phrase: "(2004"

Phrase: ")"

Phrase: "hnRNP K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "one protein multiple processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1184743:Process [Body Part, Organ, or Organ Component]
   779   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.237: Bioessays, 26, 629638.[CrossRef][ISI][Medline] Paisan-Ruiz, C., Lang, A.E., Kawarai, T., Sato, C., Salehi-Rad, S., Fisman, G.K., Al-Khairallah, T., St George-Hyslop, P., Singleton, A. and Rogaeva, E. 

Phrase: "Bioessays,"

Phrase: "26,"

Phrase: "629638."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Paisan-Ruiz,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lang,"

Phrase: "A.E.,"

Phrase: "Kawarai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sato,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Salehi-Rad,"

Phrase: "S."

Phrase: ","

Phrase: "Fisman,"

Phrase: "G.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Al-Khairallah,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A."

Phrase: "and"

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.238: (2005) LRRK2 gene in Parkinson disease. 

Phrase: "(2005"

Phrase: ")"

Phrase: "LRRK2 gene in Parkinson disease."
Processing 00000000.tx.239: Neurology, 44, 595600. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "44,"

Phrase: "595600."
Processing 00000000.tx.240: Tan, E.K., Shen, H., Tan, L.C., Farrer, M., Yew, K., Chua, E., Jamora, R.D., Puvan, K., Puong, K.Y., Zhao, Y. etal. 

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "E.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Shen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "L.C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Yew,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0330199:Yew [Plant]
  1000   C0939822:yew [Organic Chemical,Pharmacologic Substance]
  1000   C1081399:Yew [Plant]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chua,"

Phrase: "E.,"

Phrase: "Jamora,"

Phrase: "R.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Puvan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Puong,"

Phrase: "K.Y.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Zhao,"

Phrase: "Y. etal."
Processing 00000000.tx.241: (2005) The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. 

Phrase: "(2005"

Phrase: ")"

Phrase: "The G2019S LRRK2 mutation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1425650:Leucine-Rich Repeat Kinase 2 Gene [Gene or Genome]
           LEUCINE-RICH REPEAT KINASE 2
   812   C0596611:Gene Mutation [Genetic Function]
   793   C0017337:Gene [Gene or Genome]
   793   C0026882:Mutation [Genetic Function]
   793   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "uncommon in an Asian cohort of Parkinson's disease patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0522498:Uncommon [Qualitative Concept]
Processing 00000000.tx.242: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.243: Lett., 384, 327329.[CrossRef][ISI][Medline] Stephens, M., Smith, N.J. and Donnelly, P. 

Phrase: "Lett.,"

Phrase: "384,"

Phrase: "327329."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stephens,"

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "N.J."

Phrase: "and"

Phrase: "Donnelly,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.244: (2001) A new statistical method for haplotype reconstruction from population data. 

Phrase: "(2001"

Phrase: ")"

Phrase: "A new statistical method for haplotype reconstruction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1710191:Statistical Method [Research Activity]
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "from population data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.245: Am. 

Phrase: "Am."
Processing 00000000.tx.246: J. 

Phrase: "J."
Processing 00000000.tx.247: Hum. 

Phrase: "Hum."
Processing 00000000.tx.248: Genet., 68, 978989.[CrossRef][ISI][Medline] Stram, D.O., Haiman, C.A., Hirschhorn, J.N., Altshuler, D., Kolonel, L.N., Henderson, B.E. and Pike, M.C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "978989."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stram,"

Phrase: "D.O.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512020:D.O. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Haiman,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Hirschhorn,"

Phrase: "J.N., Altshuler,"

Phrase: "D."

Phrase: ","

Phrase: "Kolonel,"

Phrase: "L.N., Henderson,"

Phrase: "B.E."

Phrase: "and"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.249: (2003) Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Choosing haplotype-tagging SNPS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C2985510:Tagging SNP [Nucleotide Sequence]
   812   C0752046:SNPs [Nucleotide Sequence]
   779 E C1527094:SNP [Conceptual Entity]

Phrase: "based on unphased genotype data"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   781   C0242356:data base [Intellectual Product]
   781   C0993637:Data Base [Intellectual Product]
   760   C0017431:Genotype [Organism Attribute]
   760   C1511726:Data [Idea or Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C3245479:data [Medical Device]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a preliminary sample of unrelated subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "with an example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "from the Multiethnic Cohort Study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0009247:Cohort Study [Quantitative Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0599755:Cohort [Population Group]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.250: Hum. 

Phrase: "Hum."
Processing 00000000.tx.251: Hered., 55, 2736.[CrossRef][ISI][Medline] Weale, M.E., Depondt, C., Macdonald, S.J., Smith, A., Lai, P.S., Shorvon, S.D., Wood, N.W. and Goldstein, D.B. 

Phrase: "Hered.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "2736."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weale,"

Phrase: "M."

Phrase: "E.,"

Phrase: "Depondt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Macdonald,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A.,"

Phrase: "Lai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443021:Lai [Intellectual Product]

Phrase: "P.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]

Phrase: "Shorvon,"

Phrase: "S.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W."

Phrase: "and"

Phrase: "Goldstein,"

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.252: (2003) Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036576:selection [Genetic Function]

Phrase: "and"

Phrase: "evaluation of tagging SNPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220825:Evaluation [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]

Phrase: "in the neuronal-sodium-channel gene SCN1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1419856:SCN1A [Gene or Genome]

Phrase: ":"

Phrase: "implications for linkage-disequilibrium gene mapping."
Processing 00000000.tx.253: Am. 

Phrase: "Am."
Processing 00000000.tx.254: J. 

Phrase: "J."
Processing 00000000.tx.255: Hum. 

Phrase: "Hum."
Processing 00000000.tx.256: Genet., 73, 551565.[CrossRef][Medline] Iles, M.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "73,"

Phrase: "551565."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Iles,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022192:iles [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C0523728:ILE [Laboratory Procedure]

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.257: (2005) Obtaining unbiased estimates of tagging SNP performance. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Obtaining"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   966   C1301820:Obtain [Functional Concept]
   966   C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "unbiased estimates of tagging SNP performance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750572:estimates [Quantitative Concept]
Processing 00000000.tx.258: Ann. 

Phrase: "Ann."
Processing 00000000.tx.259: Hum. 

Phrase: "Hum."
Processing 00000000.tx.260: Genet., in press. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "in press."
Processing 00000000.tx.261: This Article Abstract Full Text (PDF) All Versions of this Article: 14/23/3549 most recent ddi376v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (1) Request Permissions Google Scholar Articles by Skipper, L. 

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "14/23/3549 most recent ddi376v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "for citing articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "in"

Phrase: ":"

Phrase: "ISI Web of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282111:Web [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Request Permissions Google Scholar Articles by Skipper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1706852:Article [Intellectual Product]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.262: Articles by Liu, J. 

Phrase: "Articles by Liu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.263: PubMed PubMed Citation Articles by Skipper, L. 

Phrase: "PubMed PubMed Citation Articles by Skipper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.264: Articles by Liu, J. 

Phrase: "Articles by Liu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.265: Online ISSN 1460-2083 - Print ISSN 0964-6906 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Online ISSN 1460-2083 - Print ISSN 0964-6906 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C2735290:Privacy policy [Intellectual Product]
   782   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

